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Abstract and Key Words 
Previous work done by the Kerr group has shown that tetrahydro-1,2-oxazines can be 
efficiently synthesized using a three component coupling reaction between a hydroxylamine, 
aldehyde and cyclopropane diester. This affords the desired heterocycle efficiently with a 
wide variety of substitution. When one esters bears an allyl group a Tsuji 
dehydrocarbonylation reaction may take place resulting in the formation of a 4,5-dihydro-
1,2-oxazine. This motif contains a vinylogously acidic proton which is extremely labile and 
easily deprotonated. Under basic conditions this proton is removed and consequently the N-O 
bond is cleaved and subsequent condensation occurs forming a pyrrole. Using a sequence of 
chemical transformations specific pyrroles generated from the above methodology could be 
transformed into either BM 212 an anti-tuberculosis drug or Atorvastatin Calcium an anti-
cholesterol drug. Each pharmaceutical will be derived using a three component coupling 
reaction and then conversion to a pyrrole followed by manipulations of the resulting 
functional groups. 
Keywords: Cyclopropanes, nitrones, tetrahydro-1,2-oxazines, 4,5-dihydro-1,2-oxazines, 
pyrroles, BM 212, Atorvastatin Calcium, Pd catalyzed, dehydrocarbonylation 
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1 Introduction Donor Acceptor Cyclopropanes and Pyrroles 
1.1 Donor Acceptor Cyclopropanes 
1.1.1 Structure and Bonding in Cylopropanes 
Since the first synthesis of the cyclopropane ring in 1881 by Freund, who treated 1,3-
dibromopropane with sodium to form the ring (Scheme 1.1), the characteristic three 
membered ring has become an unparalleled synthetic tool and has been a subject of 
interest to many synthetic organic chemists for a number of years.1  
 
Scheme 1.1 Freund's cyclopropane synthesis 
The strained carbocycle displays reactivity comparable to that of olefins. Reactions with 
a large variety of nucleophiles, electrophiles and radical species are well known to the 
scientific community.2 
The cyclopropane motif has unique physical and chemical properties that significantly 
differ from that of other alkanes and cycloalkanes. From a physical perspective the 
concept of an sp3 hybridized carbon atom in a cyclopropane ring is unheard of. A typical 
saturated alkane contains sp3 carbon atoms with tetrahedral bond geometries and bond 
angles of approximately 109.5°.1 The carbon atoms in a cyclopropane ring make up what 
is considered an equilateral triangle. Therefore the resulting interior bond angles must be 
approximately 60°. There is a 49.5° deviation in bond angle from that of a saturated 
alkane. The acuteness of the bond angle imparts a significant amount of ring strain onto 
the cyclopropane.2 In order to alleviate the angle strain present each cyclopropane, which 
traditionally appears sp3 hybridized, adopts more p character in the bonds that make up 
the ring to convey some flexibility.1 As a direct result the external bonds must contain 
more s character. This renders the C-C bonds within the ring shorter than that of normal 
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alkanes. The current most accepted model for the bonding within a cyclopropane is the 
Forster-Coulson-Moffit model seen in Figure 1.1.1 
 
Figure 1.1  Orbital structure of a cyclopropane according to the Forster-Coulson-
Moffit model 
In this mode of bonding, overlap of the C-C bonding orbitals is not along the axis of the 
bond but off centered resulting in less effective bent bonds. The weaker bonds give rise to 
the unique reactivity observed with the cyclopropane ring.1 
1.1.2 Donor Acceptor Cyclopropanes 
Activated cyclopropanes have proven to be versatile building blocks in organic synthesis. 
Their versatility arises from the ability to impart functionality into existing frameworks, 
allowing for the formation of a multitude of cyclic systems and perhaps most importantly 
the generation of carbon-carbon bonds. There are three main types of activated 
cyclopropanes:3 
I. Acceptor cylcopropanes 
II. Donor cyclopropanes 
III. Donor acceptor cyclopropanes 
Acceptor cyclopropanes contain functional groups that are electron withdrawing in nature 
and are capable of stabilizing additional electron density. Donor groups are the exact 
opposite they provide additional electron density, in turn making the cyclopropane more 
nucleophilic in character. Figure 1.2 shows general modes of reactivity for acceptor and 
donor cyclopropanes.4 
 
3 
 
 
Figure 1.2 Modes of reactivity of substituted cylcopropanes 
The final class, donor acceptor cyclopropanes contain both orthogonal functional groups 
and can be further divided into two subcategories; geminal and vicinal. Geminal DA 
systems have the orthogonal substituents on the same carbon whereas in a vicinal system 
they are on adjacent carbons (Figure 1.3).3 Vicinal DA cyclopropanes have proven to be 
much more useful due to the substitution pattern. The substituents can act synergistically 
in an electron push pull relationship.4 This electron flow makes the cyclopropane react 
similarly to a 1,3-dipole. Figure 1.3 shows the two types of DA cyclopropanes and the 
general mode of reactivity for vicinal DA systems under Lewis acidic conditions. 
AD A
D
Geminal Substitution Vicinal Substitution
A
D
Lewis Acid D A
R
R
 
Figure 1.3 DA cyclopropanes 
As seen in Figure 1.3, under Lewis Acidic conditions vicinal DA cyclopropane can act as 
a 1,3 dipole synthon in homo Michael reactions. This mode of reactivity can be exploited 
to form a variety of heterocyclic systems.4 Pyrrolidines, tetrahydropyrans and tetrahydro-
1,2-oxazines are just a few cyclic systems attainable with DA cyclopropanes. 
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1.1.3 Synthesis of DA Cyclopropanes 
1.1.3.1 Rhodium and Copper Catalyzed Cyclopropanation 
There currently exists an immense number of ways to synthesize cyclopropanes. 
Arguably the most common method is through the addition of a carbene or some 
equivalent to an alkene. This method of cyclopropanation was initially described by 
Silberrad and Roy in 1906, however it was not until many years later that the true impact 
of this process was realized. By the 1960's this method was being readily employed to 
synthesize cyclopropanes.5 Various transition metals had been screened; copper and 
rhodium catalysts had emerged as the most efficient metals of choice.  With the 
combination of a substituted carbenoid and an olefin a formal [2+1] cycloaddition can 
occur forming substituted cyclopropanes. Scheme 1.2 shows a select few reactions 
employing metal carbene complexes to synthesize DA cyclopropanes.3,6 
 
Scheme 1.2 Cyclopropanation through the use of a carbene 
Whether a diazoalkane or iodonium ylide was used, both decompose readily in the 
presence of metal catalysts to afford carbenoids capable of undergoing clean addition to 
olefins. In general catalyst turnover is very high for cyclopropanation reactions requiring 
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only up to 3 mol % in the worst of circumstances.5 More electron rich olefins react faster 
than electron deficient olefins; which in some cases fail to react at all. Electron deficient 
olefins have the tendency to form pyrazolines instead of undergoing the desired 
cyclopropanation reaction. Barring steric factors cis olefins react slightly faster than trans 
olefins.5 In cases where multiple double bonds are present the catalysts show 
regioselectivity towards the more electron rich olefins. 
This methodology has been extensively employed in laboratory scale synthesis as well as 
industrial processes. It continues to be an area of interest for many researchers and more 
recently significant discoveries have been made towards chiral catalysis (Scheme 1.3).3 
 
Scheme 1.3 Asymmetric cyclopropanations 
The size of the group attached to the diazo component has a minor influence on the 
enantioselectivity of the cyclopropanation, but greatly effects the cis/trans selectivity. 
Asymmetric cyclopropanation of simple olefins has been achieved with high selectivity 
however a significant amount still needs to be investigated to mimic these selectivities 
with more complicated olefins. Currently to date the carbenoid mediated [2+1] 
cycloaddition is the most commonly used method to synthesize DA cyclopropanes.5 
1.1.3.2 Simmons-Smith Cyclopropanation 
Moving from one transition metal catalyzed cyclopropanation to another, the Simmons-
Smith cyclopropanation utilizes CH2I2 in the presence of a zinc copper amalgam to 
stereospecifically convert unfunctionalized alkenes into cyclopropanes. The two 
discovered the reaction in 1958 while working at DuPont chemicals.7 The Simmons-
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Smith cyclopropanation is a concerted process proceeding through a butterfly like 
transition state. A slight modification by  Furukawa in 1966 is now the more commonly 
used method; instead of having to work with the complicated Zn-Cu system it is replaced 
with diethyl zinc.7 The general Simmons-Smith reaction and some applications can be 
seen in Scheme 1.4.7,8,9 
Simmons-Smith
R
R1
Zn-Cu
CH2I2
Et2O R
R1
Zn-Cu
CH2I2
Et2OR
R1
R
R1
Furukawa Modification
R1
R R2
R3
ZnEt2
R4CHI2
Et2O
R1
R R2
R3
R4
Applications
O O
Zn-Cu
CH2I2
Et2O, 35 °C
O O
O
O
O
RO H
ZnEt2
CH2I2
benzene
O
O
ORO
H
HH
1-16 1-17 1-18 1-19
1-20 1-21
1-22 1-23
1-24 1-25
 
Scheme 1.4 Applications of the Simmons-Smith cyclopropanation 
The Simmons-Smith accepts a wide range of alkenes, ranging from isolated alkenes to α, 
β unsaturated ketones and aldehydes. As was the case for the Rh and Cu catalyzed 
cyclopropanations more electron rich olefins react faster than that of electron deficient 
ones. One could use this kinetic resolution to selectively cyclopropanate one olefin over 
another.  
When cyclopropanating diastereomers the reagent always approaches from the less 
hindered face of the alkene. Asymmetric Simmons-Smith reactions are carried out 
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similarly to Rh and Cu cyclopropanations; through the use of some chiral ligand or 
auxillary a cyclopropane ring with the desired stereochemistry can be formed.7 One such 
example of an asymmetric Simmons-Smith reaction can be seen in Scheme 1.5. A slight 
modification of the original reaction was used to carry out an asymmetric 
cyclopropanation en route to the total synthesis of (+)-Ambruticin.10 
R
OH
CH3CHI2
Et2Zn
DCM, DCE
(R,R)-dioxaborolane,
-10°C, 2 h
R
OH
1-26 1-27
 
Scheme 1.5 Asymmetric Simmons-Smith 
1.1.3.3 Corey-Chaykovsky Cyclopropanation 
The final cyclopropanation reaction that will be discussed is the Corey-Chaykovsky 
cyclopropanation. Developed by Corey and Chaykovsky in 1962, they discovered that 
deprotonation of a trimethylsulfonium halide under an atmosphere of nitrogen at room 
temperature would generate a stable dimethylsulfonium methylide.11 If an α,β unsaturated 
carbonyl is treated with the dimethylsulfonium methylide reagent a conjugate addition 
takes place producing a cyclopropane. Scheme 1.6 shows the general Corey-Chaykovsky 
reaction followed by applications of the reaction.11,12 
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Scheme 1.6 Corey-Chaykovsky cyclopropanation 
This reaction is more significant to the work described here because almost all 
cyclopropanes used were synthesized using the Corey-Chakovsky reaction. It is the 
method of choice because the reagents are all inexpensive and the reaction itself can be 
carried out successfully and in high yields on large scales. 
1.1.4 Applications of Donor Acceptor Cyclopropanes 
As previously mentioned DA cyclopropanes are extremely useful to synthetic chemists. 
They have the ability to make a variety of heterocycles which can then be applied to the 
total synthesis of many natural products. Cyclopropanes can react with a wide array of 
dipolar reagent in annulation reactions to make a variety of heterocycles. Two examples 
of cyclopropane cycloadditions that were applied to the total synthesis of two natural 
products can be seen in Scheme 1.7.13,14 Both of these complex molecules were 
synthesized in the Kerr lab by Avedis Karadeolian and Cheryl Carson respectively. 
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Scheme 1.7 Reactions of cyclopropanes 
Through the use of cyclopropanes both istatisine A and (+)-phyllantidine were 
synthesized in 14 and 12 steps respectively with overall yields of 5.8 % and 6 %. 
Four other equally as significant cycloadditions with DA cyclopropanes can be seen in 
Scheme 1.8. All of the annulations pictured below were developed by the Kerr group. 
Each reaction can support a wide range of substrates and provides the cyclic systems 
rapidly and efficiently.15 
10 
 
 
Scheme 1.8 Cycloadditions with cyclopropanes 
As you can see from all the examples presented here DA cyclopropanes provide a broad 
spectrum of utility. They can be applied in almost every aspect of total synthesis but their 
greatest use is dipolar cycloaddition reactions. These reactions can allow for the 
formation of large libraries of biologically active heterocycles or for direct application 
towards the complicated and unique frameworks found in natural products. There is no 
doubt that cyclopropanes will continue to be a widespread reagent in organic synthesis. 
1.2 Pyrroles 
1.2.1 History of Pyrrole 
The pyrrole moiety is a remarkable compound since its discovery this heterocyclic 
system has been continuously found in nature at the very heart of many different 
compounds necessary for survival of living organisms. Pyrrole was first surmised in 1834 
by Runge when he observed that coal tar and bone oil contain a substance that dyes pine 
splinters red. Runge called this unidentified substance pyrrole, meaning fiery oil. 
Although he did not actually isolate the compound he is still considered the original 
11 
 
discoverer of pyrrole. It was in fact not isolated until 23 years later in 1857 when a 
scientist named Anderson converted the compound to its potassium salt. The actual 
structural formula was established in 1870 (Figure 1.4).16 
 
Figure 1.4 Structure of the pyrrole 
Pyrrole is a colourless compound, is susceptible to air oxidation and readily polymerizes 
under acidic conditions. Pyrroles are five membered aromatic systems with the lone pair 
on nitrogen delocalized through the ring. This gives the ring a total of six π electrons 
fulfilling Huckel’s rules for aromaticity. As such the pyrrole ring displays reactivity 
identical to that of an aromatic molecule.16 
The N-C1,5 and C3-C4 bond lengths are shorter than that of normal single bonds and the 
C1-C2 double bond is longer than that of a normal C-C double bond.17 The delocalization 
of the lone pair on nitrogen greatly decreases the overall basicity of nitrogen; giving 
pyrrole a negligible basicity compared to that of a secondary amine. The ring system is 
considered more electron rich than benzene, as such nucleophilic aromatic substitution is 
relatively unheard of with the pyrrole ring. However it has been documented with 
protonated forms of the ring.16 Pyrrole undergoes electrophilic aromatic substitution 
faster than that of benzene and substitution occurs preferentially at the two positions. This 
is due to the fact that a cationic intermediate at the 3 position has increased resonance 
stability than a cation at the two position (Figure 1.5).16 
H
N H HN H N H
H
N
H
H
N
H
H
 
Figure 1.5 Resonance structures of the two possible cationic intermediates during 
electrophilic aromatic substitution 
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1.2.2 Synthesis of Pyrroles 
Most pyrrole syntheses are dominated not in the interest of developing new 
methodologies but for the synthesis of pyrroles with specific substitution patterns. This 
target oriented synthesis is a direct result of the commercial success that pharmaceuticals 
containing a pyrrole motif have shown. There currently exists a vast number of resources, 
whether it be textbooks or extensive reviews on the synthesis of various forms of the 
pyrrole ring. 
The wide distribution of the pyrrole in nature is indicative of the ease of which the 
pyrrole ring is formed. This can be attributed to the favourable entropy change for five 
membered ring formation and the resulting resonance stability of the ring. Due to the 
extensive number of pyrrole syntheses the next subsections herein will report a few more 
relevant syntheses. 
1.2.2.1 Paal-Knorr Pyrrole Synthesis 
Perhaps the most famous pyrrole synthesis is the Paal-Knorr synthesis developed over 
one hundred years ago. The classic Paal-Knorr pyrrole synthesis is an acid catalyzed 
condensation of a primary amine with a 1,4-dicarbonyl compound (Scheme 1.9).18 
Because of the simplicity and availability of 1,4-dicarbonyl compounds the Paal-Knorr 
pyrrole synthesis is the most commonly used method to prepare substituted pyrroles. 
 
Scheme 1.9 Paal-Knorr pyrrole synthesis 
The Paal-Knorr reaction works on almost any masked or unmasked 1,4-dicarbonyl 
compound and allows the generation of fully substituted pyrroles. Acetic acid has been 
most commonly used acid to promote the reaction however TiCl4 has proven effective for 
more sterically encumbered substrates. The reaction has been much less successful for 
1,4-dialdehydes than 1,4-diketones because of their instability. Finally almost any type of 
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amine is accepted, whether it be electron rich, poor, aryl or ammonia.18 The Paal-Knorr 
pyrrole sythesis continues to be the most used procedure to generate pyrrole rings. 
1.2.2.2 Knorr Pyrrole Synthesis 
Developed just two years after the Paal-Knorr reaction, Knorr himself discovered that the 
combination of an α-amino ketone with another ketone under thermal and acidic 
conditions would afford a tetra-substituted N-H pyrrole (Scheme 1.10).19 
 
Scheme 1.10 Knorr pyrrole synthesis 
The reaction itself has been successful under both basic and acidic conditions. The α-
amino ketones have the tendency to self condensate so they are generally formed in-situ 
from the corresponding nitro compounds. α nitrogenation can be easily performed using 
HNO2 in the presence of acid; this allows for the generation of almost any α-amino 
ketone. N-substituted pyrroles can be synthesized from the corresponding secondary α-
amino ketones producing fully substituted systems as in the Paal-Knorr reaction.19 When 
non symmetrical ketones are used the reaction regioselectively prefers the larger 
substituent (R3) to be at C4 in the ring. Mechanistically the reaction proceeds first by 
condensation of the amine onto the ketone forming the corresponding imine. Next 
tautomerization affords the enamine which can then cyclize via nucleophilic attack onto 
the α-ketone. Finally the loss of water and a final tautomerization affords the pyrrole 
(Figure 1.6).19 
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Figure 1.6 Mechansim of the Knorr pyrrole synthesis 
1.2.2.3 Pyrroles from Donor Acceptor Cyclopropanes 
In 2003, Yu et. Al. developed a synthesis of di-, tri- and tetrasubstituted N-H pyrroles 
through the combination of DA cyclopropanes and α, β-unsaturated nitriles.20 Upon 
mixing the two components in the presence of a Lewis acid at low temperatures a cascade 
[3+2] dipolar cycloaddition, dehydration and tautomerization sequence ensued affording 
pyrroles in moderate to excellent yields (Scheme 1.11).20 
 
Scheme 1.11 Pyrroles from DA cyclopropanes and nitriles 
The reaction proved to be most successful when conducted in nitromethane with 
TMSOTf as the Lewis acid catalyst. Overall the pyrrole formation was extremely 
successful continuously providing yields between 70-90 %.20 The cycloaddition was 
shown to be effective with pyran and furan derived cyclopropanes. The diverse 
substitution permutations that are possible with this methodology enhance its significance 
one hundred fold. The domino reaction allows for precise control over the installation of 
substituents at three different positions with a fourth containing an ester which can easily 
be manipulated in a variety of different ways. It also demonstrated another one of the 
very many uses of DA cyclopropanes. 
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1.2.2.4 Nitroso Diels Alder Reactions Producing Pyrroles 
Nitroso compounds have shown potent activity in hetero Diels Alder reactions. The [4+2] 
cycloaddition reaction that occurs between nitroso compounds and dienes provides quick 
access to 4,5-dihydro-1,2-oxazines which have been previously shown to undergo a 
reductive N-O bond cleavage and recyclize to form pyrroles on silica gel. In 2005 a 
thorough investigation was conducted to determine the range of dienes viable for this 
reaction (Scheme 1.12).21 
 
Scheme 1.12 Pyrroles from a nitroso Diels-Alder reaction 
The approach used was a three step method to synthesize pyrroles. First a nitroso Diels-
Alder was conducted affording the 4,5-Dihydro-1,2-oxazines.21 Next a reductive cleavage 
of the N-O bond and subsequent oxidation to the ketone resulted in spontaneous 
condensation providing pyrrole in a total of three steps. Unfortunately due to the linear 
nature of this sequence the overall yields of the pyrroles were relatively low. The Diels-
Alder reaction could be performed in modest to high yields 51-97 % with the occasional 
low yielding substrate. Ring cleavage and condensation consistently resulted in yields 
around 75 % for each step. This provided the pyrroles in overall yields between 29-54 
%.21 The utility of this chemistry is more greatly emphasized in the substrate scope. 
Through this methodology you can generate N protected, tetra-substituted pyrroles 
through a mild and simple sequence. 
1.2.3 Importance of Pyrroles 
Since its discovery the pyrrole motif has been continuously found in nature. It has been a 
commonly used heterocycle in the synthesis of many different materials ranging from 
drugs to polymers to various dyes. The importance of this small ring system is unmatched 
by any other heterocycle.16 
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In biological systems the pyrrole ring can be found as a tetramer in two compounds 
necessary for all life on Earth, heme and chlorophyll (Figure 1.7). The structural 
backbone of both of these compounds is the porphyrin ring, a supramolecular compound 
consisting of four pyrrole units connected by a carbon spacer. In respiratory systems 
heme is what gives blood its red colour and is responsible for binding oxygen and 
transporting it throughout the body. Chlorophyll on the other hand takes part in 
photosynthesis and without it plant life would not be capable of using light energy to 
convert CO2 into sugar.22 
 
Figure 1.7 Structure of heme and chlorophyll a 
Many reviews have been provided which show the appearance and synthesis of many 
natural products containing pyrroles.23 All of these natural products show significant 
biological activity. For example mitosene a natural product isolated from Streptomyces 
caepsitosus has shown potent anticancer activity. Rebek reported the total synthesis of 
mitosene forming the penta-substituted pyrrole core via Huisgen chemistry (Scheme 
1.13).23 
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Scheme 1.13 Synthesis of penta-substituted pyrrole core of mitosene 
These are not even a small fraction of the total number of natural products containing 
pyrroles. In fact there are far too many to even attempt making a comprehensive 
catalogue of all the natural products with the pyrrole motif. These examples are being 
used only to illustrate the importance of the pyrrole ring to life and science. 
As far as drugs are concerned, as was the case with natural products there again are far 
too many to provide a comprehensive list. As such only a few examples will be given 
here. The first two are the anti-cholesterol drug Atorvastatin Calcium (Lipitor®) and the 
anti-tuberculosis drug BM 212. Their structures, modes of action and synthesis will be 
described in greater detail in the introduction to Chapter 3. For now it is important to 
simply point out that both compounds contain the pyrrole ring and are extremely 
successful at combating their specific targets. Atorvastatin Calcium has proven to be 
unmatched by any other synthetic drugs at targeting cholesterol synthesizing enzymes in 
the body. BM 212 has shown more potent activity than the drugs commonly used to 
combat tuberculosis.24 The discovery of BM 212 resulted in the creation of an entire class 
of pyrrole containing drugs targeting tuberculosis.25 
The final drug to be mentioned here is Aloracetam; a nootropic drug used for the 
treatment of Alzheimer's disease. The drug itself is a tetra-substituted pyrrole ring 
containing a pendant amide. It is readily synthesized from mono-acetylated 
ethylenediamine and hexane-2,5-dione. The commercial synthesis can be seen in Scheme 
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1.14. The drug is made in two steps, the first being a Paal-Knorr reaction between the two 
aforementioned starting materials and the second a Vilsmeier-Haack formylation 
reaction.26 
 
Scheme 1.14 Commerical synthesis of Aloracetam 
1.3 Description of Thesis 
The work described in this report will be split into two separate chapters. The first will 
encompass the synthesis of different 1-allyl-1-methylcyclopropane-1,1-dicarboxylates. 
The use of these cyclopropanes for the formation of a new type of tetrahydro-1,2-
oxazines via a three component coupling reaction. Then the one pot conversion of the 
tetrahydro-1,2-oxazines into pyrroles using a Pd catalyzed dehydrocarbonylation reaction 
followed by N-O bond cleavage and subsequent condensation forming the pyrrole ring 
(Scheme 1.15). 
 
Scheme 1.15 One pot conversion of tetrahydro-1,2-oxazines into pyrroles 
The second chapter will report the direct application of this methodology towards the 
total synthesis of both BM 212 and Lipitor® (Figure 1.8). 
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Figure 1.8 Application of the methodology to the total synthesis of BM 212 and 
Lipitor® 
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2 Synthesis of Tetrahydro-1,2-oxazines and their 
Conversion to Pyrroles 
2.1 Introduction 
The 1,3 dipole reactivity of a cyclopropane diester can be utilized to efficiently form the 
tetrahydro-1,2-oxazine heterocycle. This unique ring system was synthesized by the Kerr 
group in 2004, by utilizing a [3+3] cycloaddition between a nitrone and a cyclopropane.1 
Later that year the Kerr group refined their work and found an effective way to generate 
the nitrone in-situ prior to the addition of the cyclopropane diester (Scheme 2.1).2 This 
new method allowed for a larger substrate scope because it was no longer limited by the 
availability of nitrones. 
 
Scheme 2.1 Formation of tetrahydro-1,2-oxazines via the three component coupling 
reaction 
This heterocyclic system itself is scarcely found in nature as such preparations of this ring 
system are not abundant.3 It does however appear in several medicinally active natural 
products such as FR-900482 and FR-66979 (Figure 2.1).2 Both compounds have shown 
potent anti-tumor and antibiotic activity. As such many structural analogues with the 
tetrahydro-1,2-oxazine motif have been synthesized. 
 
Figure 2.1 FR900482 and FR66979 
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This methodology allows access to a large library of compounds with potential 
pharmaceutical activity. The one drawback to the synthesis however is the lack of 
functionality at the five position. There does exist a unique reaction that provides the 
ability to overcome this issue. In 1982 Tsuji, reported the formation of an α, β 
unsaturated ketone from a β-keto allyl ester (Scheme 2.2).4 
 
Scheme 2.2 Tsuji’s Pd catalyzed dehydrocarbonylation 
This transformation involved the use of a Pd0 catalyst resulting in the substrate 
undergoing a tandem decarbonylation and dehydrogenation reaction forming an α, β 
unsaturated ketone. If one of the geminal diesters possessed an allyl group on the 
tetrahydro-1,2-oxazine ring the above transformation could be utilized to synthesize 4,5-
Dihydro-1,2-oxazines (Scheme 2.3) 
 
Scheme 2.3 Conversion to 4,5-dihydro-1,2-oxazines 
This reaction would provide a functional handle for subsequent transformations involving 
the five position or the newly formed vinylogously acidic proton at the six position. The 
proposed catalytic cycle for this reaction can be seen in Figure 2.2.4 
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Figure 2.2 Catalytic cycle for the dehydrocarbonylation 
The catalytic cycle initiates with the coordination of Pd0 to the terminal olefin. Next an  
oxidative addition of the allyl substituent and the carboxylate group to the Pd centre 
occurs. This forms a π-allyl complex which quickly decarboxylates to eliminate CO2 and 
then rearranges placing the Pd centre alpha to the carbonyl. This allows for a β-hydride 
elimination generating an α,β-unsaturated carbonyl and finally the Pd0 catalyst is 
regenerated by the reductive elimination of propylene. 
These dihydro-1,2-oxazines have the potential to undergo a variety of new 
transformations. A few selected transformations that are possible with the new 
functionality can been seen in Figure 2.3.5 
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Figure 2.3 Possible transformations of 4,5-Dihydro-1,2-oxazines 
The work encompassed in this chapter will entail the synthesis of a new type of 
tetrahydro-1,2-oxazine bearing an allyl group on one of the geminal diesters. As well as 
the conversion of these tetrahydro-1,2-oxazines into dihydro-1,2-oxazines and the 
exploration subsequent transformations with the internal α, β unsaturated ester. 
2.2 Results and Discussion 
2.2.1 Synthesis of Substituted 1-allyl-1methylcyclopropane-1,1-
dicarboxylates 
In order to utilize Tsuji’s reaction a 1-allyl-1-methylcyclopropane-1,1-dicarboxylate was 
required. Therefore the first task necessary was the  mono trans-esterification of the 
corresponding 1,1-dimethylcyclopropane-1,1-dicarboxylates as seen in Scheme 2.4.6 
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Scheme 2.4 Selective trans esterification of  cyclopropane diesters 
Deuterium labeling experiments have shown that the rate of saponification of the trans-
ester is significantly faster than that of the cis.6 Therefore mono saponifcation is easily 
achieved without converting to the diacid. From here deprotonation of the acid with 
K2CO3 followed by an SN2 or SN2' displacement of bromine in allyl bromide by the 
carboxylate anion affords the required 1-allyl-1-methylcyclopropane-1,1-dicarboxylate. 
Figure 2.4 shows the various cyclopropanes manipulated in this study, of which 2-10c-e 
was used exclusively by other colleagues. 
 
Figure 2.4 Various Cyclopropanes Used 
2.2.2 Synthesis of Allylated Tetrahydro-1,2-Oxazines 
With the desired cyclopropanes in hand the tetrahydro-1,2-oxazines were formed 
according to the previously reported procedure.2 Using either a three component coupling 
reaction or by directly reacting a nitrone with a cyclopropane this heterocyclic motif can 
be accessed. Both methods are carried out under an inert atmosphere of Ar in the 
presence of 4 Å MS with 10 mol % of a Lewis acid catalyst; either Yb(OTf)3 or 
Sc(OTf)3, in toluene or DCM. The choice between a two or three component method was 
based on the preference of the chemist and availability of material. In this instance if 
some of the necessary nitrone was in our personal stock a two component method was 
used; otherwise a three component was chosen. Both methods afforded the tetrahydro-
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1,2-oxazines in excellent yields ranging from 84-96%. The tetrahydro-1,2-oxazines were 
formed in various diastereomeric ratios at the geminal diester carbon (C4). Table 2.1 
shows the various tetrahydro-1,2-oxazines synthesized with the 1-allyl-1-
methylcyclopropane-1,1-dicarboxylates 
 
Table 2.1 Various tetrahydro-1,2-oxazines synthesized from either a two or three 
component coupling reaction 
R1 R2 R3 Yield (%) Compound 
Ph Ph Ph 91 2-7a 
Ph Ph (E)-styryl 89 2-7b 
Ph Ph 2-furyl 93 2-7c 
Ph Ph i-Pr 85 2-7d 
Ph Ph 4-O2N-C6H4- 94 2-7ea 
Ph Tol 4-MeO-C6H4- 96 2-7fa 
Et Ph Ph 84 2-7gb 
Et Ph 2-furyl 89 2-7hb 
aFormed via the direct reaction of a nitrone with a cyclopropane. b 10 mol % Sc(OTf)3 used. 
According to the previously determined mechanism each tetrahydro-1,2-oxazine is 
formed with a cis relationship between the substituents on carbons three and six.7 2-10b 
required a much more reactive Lewis acid in order to obtain exceptional yields. Initial 
studies with Yb(OTf)3 resulted in lower yields, less than 50%, and sometimes even with 
heating the cyclopropane remained intact after extensive reaction times. Sc(OTf)3 proved 
to be a suitable catalyst improving yields significantly from less than 50% to the mid to 
high 80's at room temperature and standard reaction times. 
Paralleling problems with aliphatic cyclopropanes, aliphatic aldehydes were particularly 
obstinate with this methodology.  For example isobutyraldehyde proved to be a far too 
28 
 
stubborn reagent to work with. All three component coupling reactions involving this 
reagent required twice the amount of catalyst (20 mol %), hydroxylamine (2.6 equiv.), 
aldehyde (2.8 equiv.) and reaction times (48 h) in order to completely consume the 
cyclopropane. This is theorized to be due to the fact that aliphatic substitution cannot 
effectively stabilize the partial positive charge on the nitrone. Due to the repeated 
complications encountered with it, all examples with isobutryaldehdye were abandoned 
after formation of the 3,6-dihydro-1,2-oxazine. 
2.2.3 Tsuji Reaction and Conversion to 4,5-Dihydro-1,2-oxazines 
The next phase in our work was to investigate how well the tetrahydro-1,2-oxazines 
would fare in their conversion to 4,5-dihydro-1,2-oxazines using Tsuji's reaction. At this 
point in time it has proven difficult to functionalize this position with tetrahydro-1,2-
oxazines. It was believed that this double bond would allow access to a variety of new 
frameworks through various reactions; cross couplings, Diels-Alder reactions etc.. Using 
the conditions previously optimized by a colleague the corresponding substrate scope was 
conducted according to Table 2.2.8 
 
Table 2.2 4,5-Dihydro-1,2-oxazines synthesized using the Pd0 dehydrocarbonylation. 
R1 R2 R3 Yield (%) Compound 
Ph Ph Ph 66 2-8a 
Ph Ph (E)-styryl 46 2-8b 
Ph Ph 2-furyl 86 2-8c 
Ph Ph i-Pr 70 2-8d 
Ph Ph 4-O2N-C6H4- 79 2-8e 
Ph Tol 4-MeO-C6H4- 79 2-8f 
Et Ph Ph 85 2-8g 
Et Ph 2-furyl 89 2-8h 
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Tsuji's reaction was only successful when in refluxing CH3CN and takes approximately 3 
hours to complete. All the 4,5-Dihydro-1,2-oxazines produced were formed as a single 
isomer with the double bond between carbons four and five of the ring. In some cases the 
3,6-dihydro-1,2-oxazine (2-8a-c, 2-8g-h) produced had the same retention factor as dba. 
To circumvent this a NaBH4 workup was carried out in order to reduce the ketone on dba 
allowing the product to be separated from the ligand. In all but one case the reaction 
proceeded in modest to excellent yields (66-86%) with exception of 2-8b, only a 
maximum 46 % yield was ever obtained.  
There is however one minor drawback to using this methodology. As it currently stands 
aliphatic nitrones have to be avoided because dehydrocarbonylation reactions with 
aliphatic or benzylic nitrogen substitution are not tenable. Only aniline analogues have 
shown success with this reaction. It is speculated that the more basic nitrogen of aliphatic 
and benzylic nitrones coordinate to the Pd species thus interfering in the catalytic cycle 
resulting in poor catalyst turn-over. Reactions performed on these substrates show poor 
conversion or fail to react entirely (Figure 2.5). 
 
Figure 2.5 Limitations of the dehydrocarbonylation reaction 
After this work was completed a few test reactions were conducted to explore whether or 
not quaternization of an aliphatic nitrogen would allow for conversion to the 4,5-dihydro-
1,2-oxazine.  Unfortunately all attempts to first quaternize the 4,5-dihydro-1,2-oxazines 
failed regardless of what agent was used.  
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2.2.4 Discovery of the Dihydro-1,2-oxazine to Pyrrole Transformation 
As was our initial intentions, the 4,5-dihydro-1,2-oxazines were subjected to various 
reaction conditions in hopes that they would partake in some synthetically useful 
transformation. Whether a Diels Alder reaction or any type of cross coupling was 
attempted none of the expected product ever formed. There was just continuous recovery 
of starting material and miniscule amounts of an undesired side product whose identity at 
first perplexed us. Upon researching the 4,5-dihydro-1,2-oxazine heterocycle it was 
discovered that under basic conditions they had the potential to expel water and ring 
contract to form a pyrrole.9 We began to question then whether or not the byproduct of 
the attempted reactions was none other than a pyrrole. Upon further investigation and 
spectroscopic analysis it was concluded that the byproduct in all cases was a pyrrole. 
Figure 2.6 is the crystal structure of the first pyrrole that was synthesized and fully 
characterized confirming previous theories. 
 
Figure 2.6 Crystal structure of pyrrole 2-12d 
Pyrrole formation is not that surprising however after fully analyzing the 4,5-dihydro-1,2-
oxazine functionality. It is likely that the proton on C6 of the 4,5-dihydro-1,2-oxazines 
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would be acidic enough to be removed by the basic media of the reaction  and result in  
N-O bond cleavage and subsequent condensation resulting in the pyrrole ring.9 This is 
due to a combination of the vinylogous acidity to the methyl ester, the proximity to the 
oxygen in the ring system and in some cases the anion stabilizing effect of the adjacent 
aromatic ring. The proposed mechanism for this transformation can be seen in Figure 
2.7.5a 
 
Figure 2.7 Mechanism for the conversion of 4,5-Dihydro-1,2-oxazines into pyrroles 
Initial attempts to optimize this conversion were unsuccessful. It was believed that a 
significant degree of heating would be necessary to drive the reaction forward to facilitate 
high conversion. Preliminary reactions were all carried out at reflux or with microwave 
irradiation (Table 2.3). 
 
Table 2.3 Initial attempts at converting 4,5-Dihydro-1,2-oxazines into pyrroles. 
3,6-dihydro-1,2-
oxazine 
Equiv. of DBU Conditions Results 
2-7a 3 120 °C, 2h, µw  Decomposition 
2-7a 3 100 °C, 30 min, µw Decomposition 
2-7a 3 reflux, 2h Decomposition 
Repeated decomposition of starting material meant that the reaction was likely far more 
facile than originally thought. Moving to significantly milder conditions the 4,5-Dihydro-
1,2-oxazines were treated with NEt3 (3 equiv.) in CH3CN at room temperature for 24 
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hours. This resulted in a new highly UV active spot on the TLC plate which was 
determined to be the desired pyrrole. 
It was later determined that DBU was a much more effective base for the elimination 
reaction with all the 4,5-Dihydro-1,2-oxazines except compound 2-8e. Using DBU in 
stead of NEt3 yields increased on average by 10 % and the reaction time decreased a 
substantial amount, from 24 h to less than 5 minutes. Reactions that proceeded longer 
than 5 minutes started causing decomposition of the newly formed pyrrole. For 
compound 2-8e however NEt3 resulted in a higher yield, with a 20% average yield 
increase between all attempts with DBU it did however require the usual 24 h reaction 
time. Furthermore it is important to point out that when R1 was ethyl, NEt3 was not a 
strong enough base to promote the elimination reaction in the first place even under 
reflux conditions. Moreover when R1 was ethyl a minimum of 24 hours at 40 °C in the 
presence of DBU was necessary for the reaction to go to completion. Stopping the 
reaction any earlier would result in isolating a mixture of product and starting material. 
The general transformation can be seen in Scheme 2.5. 
 
Scheme 2.5 Conversion of 4,5-dihydro-1,2-oxazines into pyrroles 
After determining the optimal conditions for both the dehydrocarbonylation reaction and 
pyrrole conversion a one pot method was attempted in order to see if the tetrahydro-1,2-
oxazines could be converted into pyrroles directly. To do so the dehydrocarbonylation 
reaction was carried out under the same conditions and after the allotted time the reaction 
was cooled to room temperature and DBU was added directly. Table 2.4 shows the small 
subset of different pyrroles synthesized for investigatory purposes by both a one pot 
procedure and two pot with their respective yields.  
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Table 2.4 Two reaction conversion of tetrahydro-1,2-oxazines to pyrroles. 
Tetrahydro-
1,2-oxazine 
Pyrrole Reaction A 
Yield (%) 
Reaction B 
Yield (%) 
Overall 
Yield (%) 
One Pot 
Yield (%) 
2-7a 2-12a 66 88 58 76 
2-7e 2-12d 79 98 77 79 
2-7f* 2-12e 79 96 76 95 
* NEt3 was used instead of DBU for 24 h at room temperature. 
Much to our delight there was an improvement going from the two reactions to the one 
pot.  As such all of the pyrroles were synthesized using the one pot procedure. Table 2.5 
shows the yields of each pyrrole synthesized using the one pot procedure. 
 
Table 2.5 Various pyrroles synthesized from a one pot reaction. 
R1 R2 R3 Yield (%) Compound 
Ph Ph Ph 76 2-12a 
Ph Ph (E)-styryl 48 2-12b 
Ph Ph 2-furyl 69 2-12c 
Ph Ph 4-O2N-C6H4- 79 2-12da 
Ph 4-tol 4-MeO-C6H4- 95 2-12e 
Et Ph Ph 73 2-12fb 
Et Ph 2-furyl 50 2-12gb 
a
 NEt3 was used instead of DBU, bheated at 40 °C overnight 
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2.3 Conclusions 
As demonstrated the 1-ally-1-methylcyclopropane-1,1-dicarboxylates proved to be 
exceptional substrates for the [3+3] cycloaddition reaction. A wide variety of tetrahydro-
1,2-oxazines could be synthesized as diastereomeric mixtures with outstanding yields. 
The reaction supported a wide range of substitution however due to the requirements of 
subsequent reactions the substrate scope was limited to N-aryl hydroxylamines. The N-
aryl tetrahydro-1,2-oxazines with the decreased nucleophilicity at nitrogen behaved as 
desired in the catalytic dehydrocarbonylation reaction. The overall yields of this reaction 
were modest but the most intriguing aspect of the chemistry of the dihydro-1,2-oxazines 
was their rapid conversion to pyrroles. Utilizing a one pot reaction drastically increased 
the overall yield of the pyrroles.  
In summary the multi-component synthesis of pyrroles through the use of DA 
cyclopropanes could very well prove to be a commonly used route to synthesize 
pharmaceutically active compounds. 
2.4 Experimental 
2.4.1 General Considerations 
All reactions were performed under an atmosphere of Ar unless otherwise indicated.  
Toluene, acetonitrile, N,N-dimethylformamide (DMF), and dichloromethane were dried 
and deoxygenated by passing the nitrogen purged solvents through activated alumina 
columns. All other reagents and solvents were used as purchased from Sigma Aldrich, 
Alfa Aesar, Caledon, Strem or VWR and used as received.  Reaction progress was 
monitored by TLC (EM Science, silica gel 60 F254), visualizing with UV light, and the 
plates developed with p-anisaldehyde, vanillin, or basic potassium permanganate stains.  
Column chromatography was performed using silica gel (230-400 mesh, Silicycle 
Chemical Division Inc). 
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NMR experiments were performed on Varian Mercury 400, Inova 400 and Inova 600 
MHz instruments with 13C operating frequencies of 100, 100 and 125 MHz respectively.  
Chemical shifts are reported in ppm relative to the residual solvent signal (CDCl3, 
referenced to residual CHCl3 at δ = 7.26 for 1H and δ = 77.0 for 13C).  Coupling constants 
(J) are reported in Hz, and multiplicities of the signals are described using the following 
abbreviations: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad.  
High resolution mass spectra (HRMS) were obtained on a Finnigan MAT 8200 or 8400 
mass spectrometer at an ionizing voltage of 70 eV.  Melting points were determined 
using a Gallenkamp melting point apparatus and are uncorrected.  Infrared spectra were 
obtained as thin films on NaCl plates using a Bruker Vector 33 FT-IR instrument and are 
reported in frequency of absorption (cm-1). 
2.4.2 General Procedure and Spectral Data for 1,1-
cyclopropanediesters 
 
To a 1M solution of NaOH (1.2eq.) in an equal volume of MeOH was added the desired 
1,1-dimethylcyclopropane-1,1-dicarboxylate. Upon complete saponification of one ester 
based on TLC analysis the reaction was acidified to pH 4 with 4M HCl and the 
cyclopropane was extracted with Et2O. Removal of solvent under reduced pressure 
afforded the cyclopropane ester acid. The ester acid was then dissolved in DMF and 
cooled to 0°C. At this point 1.1eq. of K2CO3 was added in and the solution was allowed 
to stir for 30 minutes. After which time allyl bromide was added dropwise and the 
reaction mixture continued to stir until the ester acid was consumed based on TLC 
analysis. From here H2O was added to the reaction flask and the organics were extracted 
with Et2O and the cyclopropane methyl allyl diesters were purified by flash column 
chromatography (10% EtOAc in hexanes). 
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(1R*,2S*)-1-allyl-1-methyl-2-phenylcyclopropane-1,1-dicarboxylate -
(2-10a): yellow oil; Rf = 0.50  (30% EtOAc/hexanes); ); 1H NMR (600 
MHz, CDCl3) δ 7.28−7.19 (m, 5H), 5.93 (ddt, J = 17.2, 10.6, 5.5 Hz, 1H), 
5.35 (dq, J = 18, 1.8 Hz, 1H), 5.25 (dq, J = 9 Hz, 1.2 Hz, 1H), 4.69 (ddt, J = 5.4, 1.8 Hz, 
2H), 3.37 (s, 3H), 3.25 (t, J = 8.6 Hz, 1H), 2.21 (dd, J = 7.8, 5.1 Hz, 1H), 1.76 (dd, J = 
9.4, 5.1 Hz, 1H); 13C NMR (400 MHz, CDCl3) δ 169.4, 166.9, 134.5, 131.6, 128.4, 
128.1, 127.4, 118.2, 110.8, 66.1, 52.1, 42.1, 37.3, 32.5, 19.1; FT-IR (thin film, cm-1) νmax 
2951, 1728 , 1500, 1437, 1382, 1333, 1274, 1217, 1180, 1130, 984, 933, 793, 750, 698, 
453, 418; HRMS calc’d for C15H16O4 [M+] 260.1049, found 260.1042. 
             
(1R*,2R*)-1-Allyl-1-methyl-2-ethylcyclopropane-1,1-dicarboxylate (2-
10b): Colourless oil; Rf = 0.50 (30% EtOAc/hexanes); 1H NMR (400 MHz, 
CDCl3); δ 5.95−5.83 (m, 1H), 5.31 (dq, J = 17.2, 1.6 Hz, 1H), 5.22 (dq, J = 10.6, 1.6 Hz, 
1H), 4.96−4.55 (m, 2H), 3.76 (s, 3H), 1.89 (quintet, J = 7.8 Hz, 1H), 1.49−1.36 (m, 3H), 
1.29−1.20 (m, 1H), 1.00 (t, J = 7.4 Hz, 3H); 13C NMR (400 MHz, CDCl3) δ 170.1, 
168.7¸ 131.8, 118.0, 65.8, 52.4, 34.2, 30.4, 22.1, 21.2, 13.2; FT-IR (thin film, cm-1) νmax 
2965, 1728, 1437, 1329, 1283, 1260, 1209, 1131, 1103; HRMS calc'd for C11H16O4 [M+] 
212.1049, found 212.1045. 
             
2.4.3 Synthesis of Tetrahydro-1,2-oxazines 
General Method A – Two-Component Coupling 
The desired nitrone (1.3 equiv) was added to a solution of 1,1-cyclopropanediester (1.0 
mmol) and Yb(OTf)3 (10 or 20 mol %) in toluene (5−10 mL).  The reaction was stirred at 
room temperature, for the time indicated, under an atmosphere of argon.  On completion, 
the reaction mixture was filtered through celite, pre-adsorbed onto silica gel, and purified 
by column chromatograpy (silica gel, EtOAc/hexanes). 
 
CO2Me
CO2allyl
CO2Me
CO2allyl
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General Method B – Three-Component Coupling 
Hydroxylamine (1.3 mmol), aldehyde (1.4 mmol) and Yb(OTf)3 (10 or 20 mol %) were 
stirred under an atmosphere of argon at room temperature in the presence of 4 Å 
molecular sieves in toluene (5−10 mL) for 0.5 h.  Once the nitrone was formed in situ, 
1,1-cyclopropanediester (1.0 mmol), dissolved in 1−2 mL of toluene, was added to the 
reaction mixture in one portion. The reaction was stirred at room temperature, for the 
time indicated, under an atmosphere of argon.  On completion, the reaction mixture was 
filtered through celite, pre-adsorbed onto silica gel, and purified by column 
chromatograpy (silica gel, EtOAc/hexanes). 
             
4-Allyl-4-methyl-2,3,6-triphenyl-1,2-oxazine-4,4-dicarboxylate (2-
7a): Following general procedure B, phenylhydroxylamine (55 mg, 0.50 
mmol), benzaldehyde (57 mg, 55 uL, 0.54 mmol), cyclopropane 1 (0.10 
g, 0.38 mmol), and Yb(OTf)3 (24 mg, 10 mol %) heated in toluene (5 mL) for 20 h, gave 
4, after filtration and purification (column chromatography, EtOAc/hexanes 2, 4, 10%), 
as a pale yellow viscous oil (91 %, 0.16 mg, 0.35 mmol, 1:1 diastereomeric mixture at 
C4); Rf = 0.47 (30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.62−7.54 (m, 7H), 
7.47 (t, J = 7.0 Hz, 3H), 7.42−7.37 (m, 2H), 7.22−7.16 (m, 6H), 7.15−7.08 (m, 6H), 
6.84−6.79 (m, 2H), 5.99 (ddt, J = 17.2, 10.6, 5.5 Hz, 1H), 5.81 (s, 2H), 5.64 (ddt, J = 
17.2, 10.6, 5.5 Hz, 1H), 5.41 (dq, J = 17.2, 1.2 Hz, 1H), 5.30 (dq, J = 10.2, 1.2 Hz, 1H), 
5.21−5.13 (m, 2H), 5.05 (dt, J = 12.1, 2.7 Hz, 2H), 4.84 (dt, J = 5.9, 1.2 Hz, 1H), 4.39 
(dd, J = 15, 6 Hz, 1H), 4.28 (dd, J = 15, 6 Hz, 1H), 3.93 (s, 3H), 3.48 (s, 3H), 2.94−2.77 
(m, 4H); 13C NMR (100 MHz, CDCl3) δ 170.0, 169.1, 168.1, 167.4, 148.5, 139.4, 135.0, 
134.8, 131.4, 131.0, 130.6, 130.3, 128.6, 128.5, 128.4, 128.2, 128.1, 128.0, 127.9, 127.9, 
127.3 126.4 126.3 78.8, 66.7, 66.2, 65.8, 59.5, 53.4, 52.5, 37.3, 32.4, 31.7, 31.6, 19.0; 
FT-IR (thin film, cm-1) νmax 3030, 2952, 1732, 1599, 1942, 1453, 1228, 1064, 988, 944, 
911, 810, 734, 700, 650, 600;  HRMS calc’d for C28H27NO5 [M+] 457.1889, found 
457.1886. 
N
O
CO2allyl
CO2Me
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4-Allyl-4-methyl-2,6-diphenyl-3-[(E)-styryl]-1,2-oxazine-4,4-
dicarboxylate (2-7b): Following general procedure B, 
phenylhydroxylamine (55 mg, 0.50 mmol), cinnamaldehyde (71 mg, 
67 uL, 0.54 mmol), cyclopropane 1 (0.10 g, 0.38 mmol), and Yb(OTf)3 (24 mg, 10 mol 
%) heated in toluene (5 mL) for 20 h, gave 5, after filtration and purification (column 
chromatography, EtOAc/hexanes 2, 4, 10%), as a pale yellow viscous oil (89 %, 0.17 g, 
0.35 mmol, 1:1 diastereomeric mixture at C4); Rf = 0.56 (30%, EtOAc/hexanes); 1H 
NMR (400 MHz, CDCl3) δ 7.54−7.51 (m, 4H), 7.44 (t, J = 7.0 Hz, 4H), 7.39−7.36 (m, 
2H), 7.26−7.17 (m, 14H), 7.14 (app d, J = 9.0 Hz, 4H), 6.91 (t, J = 7.0 Hz, 2H), 
6.50−6.47 (m, 4H), 5.99 (ddt, J = 17.2, 10.6, 5.5 Hz, 1H), 5.80 (ddt, J = 17.2 , 10.6, 5.9 
Hz, 1H), 5.42 (dq, J = 17.2, 1.6 Hz 1H), 5.32−5.29 (m, 2H), 5.25−5.23 (m, 2H), 5.16 (dd, 
J = 10.2, 1.2 Hz, 1H), 5.07−5.02 (m, 2H), 4.83 (d, J = 5.5 Hz, 2H), 4.56 (dq, J = 5.9, 1.6 
Hz, 2H), 3.92 (s, 3H), 3.68 (s, 3H), 2.82 (d, J = 14.0 Hz, 2H), 2.62−2.55 (m, 2H); 13C 
NMR (100 MHz, CDCl3) δ 169.6, 168.7, 168.3, 167.6, 148.7, 139.6, 139.5, 136.7, 136.5, 
136.3, 136.2, 131.5, 131.3, 128.6, 128.5, 128.4 (×2), 128.3, 127.8, 126.6, 126.4 (×2), 
122.1, 120.1, 120.5, 119.1, 118.9, 116.3, 78.9, 66.8, 66.7, 66.5, 59.4, 55.3, 52.9, 32.6, 
32.5; FT-IR (thin film, cm-1) νmax 3027, 2951, 1739, 1598, 1494, 1451, 1436, 1273, 
1234, 1045, 967, 751, 695. HRMS calc’d for C30H29O5N [M+] 483.2046, found 
483.2052. 
             
4-Allyl-4-methyl-3-(furan-2-yl)-2,6-diphenyl-1,2-oxazine-4,4-
dicarboxylate (2-7c): Following general procedure B, 
phenylhydroxylamine (54 mg, 0.50 mmol), 2-furaldehyde (52 mg, 45 
uL, 0.54 mmol), cyclopropane 1 (0.10 g, 0.38 mmol), and Yb(OTf)3 (24 mg, 10 mol %) 
heated in toluene (5mL) for 20 h, gave 6, after filtration and purification (column 
chromatography, EtOAc/hexanes 2, 4, 10%), as a pale yellow viscous oil (93 %, 0.16 g, 
0.36 mmol, 1:1 diastereomeric mixture at C4); Rf = 0.48 (30%, EtOAc/hexanes); 1H 
NMR (400 MHz, CDCl3) δ 7.58−7.54 (m, 4H), 7.46 (app t, J = 7.0 Hz, 4H), 7.42−7.38 
N
O
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(m, 2H), 7.33−7.30 (m, 2H), 7.29−7.24 (m, 4H), 7.16 (d, J = 8.2 Hz, 4H), 6.97 (app t, J = 
7.0 Hz, 2H), 6.34 (dd, J = 3.5, 10.6 Hz, 2H), 6.25 (q, J = 2.0 Hz, 2H), 6.08-5.99 (m, 1H), 
5.93 (s, 2H), 5.81−5.71 (m, 1H), 5.46 (dq, J = 17.2, 1.6 Hz, 1H), 5.34 (d, J = 10.6 Hz, 
1H), 5.28−5.21 (m, 2H), 5.14−5.10 (m, 2H), 4.88 (d, J = 5.5 Hz, 2H), 4.56 (d, J = 5.5 Hz, 
2H), 3.96 (s, 3H), 3.67 (s, 3H), 2.93−2.83 (m, 4H); 13C NMR (100 MHz, CDCl3) δ 
169.3, 168.4, 168.0, 167.2, 148.5, 148.4, 141.9, 141.8, 139.5, 131.4, 131.1, 128.5, 128.2, 
126.5, 126.4, 122.3 (×2), 119.0, 118.9, 116.3, 116.2, 110.9, 110.1, 79.0, 66.8, 66.4, 61.7, 
58.3, 53.4, 52.8, 32.9, 32.8; FT-IR (thin film, cm-1) νmax 3063, 3032, 2953, 2255, 1740, 
1599, 1492, 1453, 1221, 1063, 1045, 1029, 1014, 911, 800, 736, 698, 649, 599; HRMS 
calc’d for C26H25NO6 [M+] 447.1682; found 447.1700. 
             
4-Allyl-4-methyl-3-isopropyl-2,6-diphenyl-1,2-oxazine-4,4-
dicarboxylate (2-7d): Following general procedure B, 
phenylhydroxylamine (54 mg, 0.50 mmol), isobutyraldehyde (39 mg, 49 
uL, 0.54 mmol), cyclopropane 1 (0.10 g, 0.38 mmol), and Yb(OTf)3 (24 mg, 10 mol %) 
heated in toluene (5 mL) for 20 h, gave 7, after filtration and purification (column 
chromatography, EtOAc/hexanes 2, 4, 10%), as a pale yellow viscous oil (85 %, .14 g, 
0.33 mmol, 1:1 diastereomeric mixture at C4); Rf = 0.53 (30%, EtOAc/hexanes); 1H 
NMR (400 MHz, CDCl3) δ 7.50−7.45 (m, 4H), 7.41 (app t, J = 7.0 Hz, 4H), 7.39−7.34 
(m, 2H), 7.25−7.19 (m, 4H), 7.06−7.04 (m, 4H), 6.79 (app t, J = 7.0 Hz, 2H), 5.97-5.85 
(m, 2H), 5.37 (dq, J = 9.8, 1.2 Hz, 1H), 5.35−5.23 (m, 3H), 4.83 (quintet, J = 4.7 Hz, 
2H), 4.77−4.64 (m, 5H), 4.60−4.53 (m, 1H), 3.80 (s, 3H), 3.76 (s, 3H), 2.72−2.67 (m, 
4H), 2.45 (sextet, J = 7.4 Hz, 2H), 0.93 (t, J = 6.3 Hz, 6H), 0.87 (dd, J = 6.6, 3.5 Hz, 6H); 
13C NMR (100 MHz, CDCl3) δ 170.3, 169.5, 169.4, 168.7, 149.2, 139.6, 131.6, 131.0, 
128.8, 128.7, 128.5, 128.2, 126.4, 126.3, 119.1, 119.0, 118.9, 112.3, 112.4, 79.2, 66.6, 
66.4, 66.2, 58.8, 53.1, 52.6, 33.5, 29.5, 22.4, 21.9; FT-IR (thin film, cm-1) νmax 2953, 
1738, 1597, 1494, 1454, 1435, 1241, 1203, 1175, 1091, 1056, 987, 938, 749, 696, 605, 
543; HRMS calc’d for C25H29NO5 [M+] 423.2046, found 423.2041. 
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4-Allyl-4-methyl-3-(4-nitrophenyl)-2,6-diphenyl-1,2-oxazine-4,4-
dicarboxylate (2-7e): Following general procedure A, nitrone (0.12 
g, .50 mmol), cyclopropane 1 (0.10 g, 0.38 mmol), and Yb(OTf)3 
(24 mg, 10 mol %) heated in toluene (5 mL) for 20 h, gave 8, after 
filtration and purification (column chromatography, EtOAc/hexanes 2, 4, 10%), as a pale 
yellow powder (94 %, 0.18 g, 0.36 mmol, 1.03:1 diastereomeric mixture at C4); Rf = 
0.36 (30%, EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 810−8.01 (m, 3H), 
7.83−7.76 (m, 3H) 7.58−7.52 (m, 3H), 7.49 (t, J = 7.0 Hz, 3H), 7.45−7.40 (m, 1H), 7.17 
(t, J = 7.0 Hz, 3H), 7.08 (d, J = 7.8 Hz, 3H), 6.86 (t, J = 7.0 Hz, 1H), 6.06-5.94 (ddt, J = 
17.2, 10.6, 5.9 Hz, 1H), 5.92 (s, 1H), 5.73-5.61 (ddt, J = 17.2, 10.6, 5.9 Hz, 2H), 5.42 
(dd, J = 17.2, 1.8 Hz, 1H), 5.33 (d, J = 10.6, 1.8 Hz, 1H), 5.21−5.17 (m, 2H), 5.13−5.06 
(dt, J = 12.1, 2.7 Hz, 3H), 4.86 (d, J = 5.5 Hz, 1H), 4.49−4.29 (m, 2H), 3.96 (s, 3H), 3.53 
(s, 1H), 2.91 (d, J = 2.7 Hz, 1H), 2.87 (d, J = 2.7 Hz, 2H), 2.84−2.74 (m, 1H); 13C NMR 
(100 MHz CDCl3) δ 169.4, 168.5, 167.8, 167.1, 148.0, 147.5, 142.7, 142.5, 138.8, 131.5, 
131.3, 130.6, 128.8, 128.6, 126.3 (×2), 123.0 (×2), 122.3 (×2), 119.4 (×2), 115.8, 78.8, 
66.6, 65.5, 59.2, 53.7, 31.6; FT-IR (thin film, cm-1) νmax 3034, 2953, 2361, 1740, 1598, 
1522, 1493, 1453, 1349, 1255, 1227, 1177, 1065, 944, 911, 861, 754, 697, 598, 546; 
HRMS calc’d for C28H26N2O7 [M+] 502.1740, found 502.1756. 
             
4-Allyl-4-methyl-3-(4-methoxyphenyl)-6-phenyl-2-(p-tolyl)-1,2-
oxazine-4,4-dicarboxylate (2-7f): Following general procedure A, 
the nitrone (0.12 g, 0.50 mmol), cyclopropane 1 (0.10 g, 0.38 
mmol), and Yb(OTf)3 (24 mg, 10 mol %) heated in toluene (5 mL) for 20 h, gave 9, after 
filtration and purification (column chromatography, EtOAc/hexanes 2, 4, 10%), as a 
white powder (96 %, 0.19 g, 0.36 mmol, 1:1 diastereomeric mixture at C4); Rf = 0.44 
(30%, EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.64−7.51 (m, 8H), 7.48 (app t, J 
= 7.0 Hz, 4H), 7.44−7.37 (m, 2H), 6.99 (app q, J = 8.2, 8H), 6.78−6.69 (m, 4H), 6.00 
(ddt, J = 16.8, 10.6, 5.5 Hz, 1H), 5.78-5.63 (m, 3H), 5.42 (d, J = 17.2 Hz, 1H), 5.31 (d, J 
= 10.6 Hz, 1H), 5.25−5.15 (m, 2H), 5.07 (d, J = 11.3 Hz, 2H), 4.85 (d, J = 5.1 Hz, 2H), 
4.48−4.25 (m, 2H), 3.94 (s, 3H), 3.72 (s, 6H), 3.51 (s, 3H), 2.94−2.76 (m, 4H), 2.20 (s, 
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6H); 13C NMR (100 MHz, CDCl3) δ 170.1, 169.2, 168.3, 167.5, 159.1, 159.0, 146.3, 
139.6, 131.8, 131.6, 131.5, 131.1, 130.9 (×2), 129.0, 128.6, 128.2, 127.0, 126.9, 126.4, 
126.3, 118.8, 116.0, 113.2, 78.6, 66.7, 66.2, 65.6, 59.6, 54.9, 53.4, 52.5, 31.7, 31.6, 20.5; 
FT-IR (thin film, cm-1) νmax 3031, 3002, 2953, 2837, 1740, 1610, 1580, 1511, 1454, 
1305, 1254, 1177, 1081, 1035, 943, 911, 841, 762, 733, 699, 650, 602, 573, 532, 489; 
HRMS calc’d for C30H31NO6 [M+] 501.2151, found 501.2151 
             
4-Allyl-4-methyl-2,3-diphenyl-6-vinyl-1,2-oxazinane-4,4-
dicarboxylate (2-7g): Following general procedure B, 
phenylhydroxylamine (67 g, 0.61 mmol), benzaldehyde (70 g, 67 uL, 
0.66 mmol), cyclopropane 2 (0.10 g, 0.47 mmol), and Sc(OTf)3 (23 mg, 10 mol %) 
heated in toluene (5 mL) for 24 h, gave 10, after filtration and purification (column 
chromatography, EtOAc/hexanes 2, 4, 10%), as a pale yellow viscous oil (84 %, 0.16 g, 
0.40 mmol, 1:1 diastereomeric mixture at C4); Rf = 0.45 (30% EtOAc/hexanes); 1H 
NMR (400 MHz, CDCl3) δ 7.55−7.50 (m, 4H), 7.20−7.11 (m, 10H), 7.09−7.04 (m, 4H), 
6.79 (td, J = 7.0, 1.2 Hz, 2H), 5.95(ddt, J = 16.8, 10.2, 5.5 Hz, 1H), 5.71 (s, 2H), 5.65 
(ddt, J = 17.2, 10.2, 5.5 Hz, 1H), 5.37 (dq, J = 17.2, 1.2 Hz, 1H), 5.26 (dd, J = 10.6, 1.2 
Hz, 1H), 5.21−5.14 (m, 2H), 4.80−4.75 (m, 2H), 4.41−4.28 (m, 2H), 3.94−3.88 (m, 2H), 
3.87 (s, 3H), 3.47 (s, 3H), 2.49−2.43 (m, 4H), 1.91−1.77 (m, 2H), 1.77-1.67 (m, 2H), 
1.14 (td, J = 7.4, 2.7 Hz, 6H); 13C NMR (100 MHz, CDCl3) δ 170.2, 169.3, 168.4, 167.7, 
148.7, 135.2, 135.0, 131.5, 131.1, 130.6, 130.4, 128.5, 127.9 (×2), 127.8, 121.2, 118.7 
(×2), 115.5, 78.4, 66.6, 66.2, 65.4, 59.2, 53.3, 52.5, 30.9, 27.7, 10.1; FT-IR (thin film, 
cm-1) νmax 3061, 3028, 2966, 2879, 1741, 1598, 1492, 1452, 1229, 1197, 1142, 1085, 
1032, 954, 912, 810, 754, 701, 636, 599; HRMS calc’d for C24H27NO5 [M+] 409.1889, 
found 409.1882. 
             
4-Allyl-4-methyl-6-ethyl-3-(furan-2-yl)-2-phenyl-1,2-oxazinane-4,4-
dicarboxylate  (2-7h): Following general procedure B, 
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phenylhydroxylamine (67 mg, 0.61 mmol), 2-furaldehyde (63 mg, 54 uL, 0.66 mmol), 
cyclopropane 2 (0.10 g, 0.47 mmol), and Sc(OTf)3 (23 mg, 10 mol %) heated in toluene 
(5 mL) for 24 h, gave 11, after filtration and purification (column chromatography, 
EtOAc/hexanes 2, 4, 10%), as a pale yellow viscous oil (89 %, 0.17 g, 0.42 mmol, 1:1 
diastereomeric mixture at C4); Rf = 0.45 (30% EtOAc/hexanes); 1H NMR (400 MHz, 
CDCl3) δ 7.25−7.19 (m, 6H), 7.10−7.06 (m, 4H), 6.94−6.87 (m, 2H), 6.24 (dd, J = 8.2, 
3.1 Hz, 2H), 6.18 (q, J = 4.0 Hz, 2H), 5.94 (ddt, J = 17.2, 10.2, 5.9 Hz, 1H), 5.80 (s, 2H), 
5.72 (ddt, J = 17.2, 10.6, 5.9 Hz, 1H), 5.37 (dq, J = 16.0, 4.0 Hz, 1H), 5.27 (dd, J = 10.6, 
1.2 Hz, 1H), 5.24-5.16 (m, 2H), 4.77 (d, J = 4.0 Hz, 2H), 4.51-4.48 (m, 2H), 3.96−3.86 
(m, 2H), 3.87 (s, 3H), 3.62 (s, 3H), 2.54 (d, J = 12.0 Hz, 2H), 2.38−2.29 (m, 2H), 
1.79−1.60 (m, 4H), 1.09 (td, J =  8.0, Hz, 6H); 13C NMR (100 MHz, CDCl3) δ 169.5, 
168.6, 168.3, 167.5, 148.8, 148.7, 148.6, 141.7, 141.6, 131.4, 131.3, 128.5, 122.0, 121.9, 
118.8, 118.6, 115.9, 115.8, 110.8, 110.7, 110.1, 78.4, 78.4, 66.7, 66.3, 61.3, 61.2, 58.1, 
58.0, 53.3, 52.8, 31.6, 31.5, 27.5, 27.4, 10.0; FT-IR (thin film, cm-1) νmax 2966, 2880, 
2360, 1740, 1598, 1492, 1455, 1436, 1240, 1221, 1199, 1145, 1013, 964, 934, 757, 693, 
599, 575; HRMS calc’d for C22H25NO6 [M+] 399.1682, found 399.1678. 
             
2.4.4 Synthesis of 4,5-dihydro-1,2-oxazines 
To a solution of tetrahydro-1,2-oxazine (1 mmol) in CH3CN (3−5 mL) was added 
Pd2dba3 (6 mol %). The solution was placed under Ar and brought to reflux (80 °C) for 3 
h. At this time, the reaction was cooled to room temperature and filtered through celite. 
Note: for compounds co-eluting with dba (compound 2-8a-d, g, h), the following work-
up procedure was used: the reaction residue was dissolved in MeOH (3 mL) and NaBH4 
(1.2 equiv/ mmol dba) was added to reduce dba to the corresponding alcohol because the 
pyrroles and dba co-eluted. After all the dba was reduced based on TLC analysis the 
organics were collected via extraction with Et2O. The extract was absorbed onto silca and 
the solvent was removed by reduced pressure. Pure product was obtained by flash column 
chromatography on silica gel (eluent: EtOAc in hexanes). 
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Methyl-2,3,6-triphenyl-3,6-dihydro-2H-1,2-oxazine-4-carboxylate 
(2-8a): Following the general procedure, tetrahydro-1,2-oxazine 2-7a 
(0.19 g, 0.74 mmol) and Pd2dba3 (40 mg, 6 mol %) were brought to 
reflux in CH3CN (5 mL) for 3 h. Filtration and purification (silica gel column 
chromatography, EtOAc/hexanes 2, 4, 10%) provided dihydro-1,2-oxazine 2-8a (66%, 
0.10 g, 0.28 mmol) as a white powder; Rf = 0.43 (30% EtOAc/hexanes); 1H NMR (400 
MHz, CDCl3) δ 7.56−7.51 (m, 2H), 7.50−7.40 (m, 3H), 7.37−7.30 (m, 3H), 7.23−7.16 
(m, 5H), 7.04 (d, J = 7.8 Hz, 2H), 6.91 (t, J = 7.0 Hz, 1H), 5.75 (s, 1H), 5.58 (s, 1H), 3.72 
(s, 3H); 13C NMR (100 MHz, CDCl3) δ 175.3 165.2, 148.0, 139.7, 136.7, 136.5, 131.1, 
129.5, 128.9, 128.9, 128.6, 127.9, 127.7, 122.3, 117.0, 78.6, 62.9, 52.0; FT-IR (thin film, 
cm-1) νmax 3061, 3031, 2951, 2846, 2360,  1719, 1598, 1493, 1453, 1436, 1245, 1078, 
1029, 909, 735, 696, 667, 627, 696; HRMS calc’d for C24H21NO3 [M+] 371.1521, found 
371.1519. 
             
(3R,6R)-methyl-2,6-diphenyl-3-styryl-3,6-dihydro-2H-1,2-oxazine-
4-carboxylate (2-8b): Following the general procedure, tetrahydro-
1,2-oxazine 2-7b (98 mg, 0.20 mmol) and Pd2dba3 (11 mg, 6 mol %) 
were brought to reflux in CH3CN (5 mL) for 3 h. Filtration and purification (silica gel 
column chromatography, EtOAc/hexanes 2, 4, 10%) provided dihydro-1,2-oxazine 2-8b 
(46%, 37 mg, 0.09 mmol) as a yellow oil; Rf = 0.45 (30% EtOAc/hexanes); 1H NMR 
(400 MHz, CDCl3) δ; 7.51-7.41 (m, 5H), 7.32-7.24 (m, 7H), 7.22-7.13 (m, 4H), 6.95 (app 
t, J = 7.4 Hz, 1H), 6.69 (d, J = 16.0 Hz, 1H), 6.33 (dd, J = 16.0, 7.4 Hz, 1H), 5.72 (s, 
1H), 5.26 (d, J = 7.8 Hz, 1H), 3.81 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 165.1, 148.0, 
139.6, 136.6, 134.7, 130.7, 129.0, 128.8 (x2), 128.4, 128.1, 127.6, 126.5, 124.5, 122.0, 
116.2, 79.5, 60.4, 52.0; FT-IR (thin film, cm-1) νmax  3061, 3030, 2950, 2360, 2249, 1719, 
1597, 1493, 1452, 1436, 1248, 965, 908, 758, 694, 504; HRMS calc’d for C26H23NO3 
[M+] 397.1678, found 397.1687. 
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(3S,6R)-methyl-3-(furan-2-yl)-2,6-diphenyl-3,6-dihydro-2H-1,2-
oxazine-4-carboxylate (2-8c): Following the general procedure, 
tetrahydro-1,2-oxazine 2-7c (81 mg, 0.22 mmol) and Pd2dba3 (5.0 mg, 6 
mol %) were brought to reflux in CH3CN (5 mL) for 3 h. Filtration and purification 
(silica gel column chromatography, EtOAc/hexanes 2, 4, 10%) provided dihydro-1,2-
oxazine 2-8c (86%, 55 mg, 0.19 mmol) as a white powder; Rf = 0.40 (30% 
EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.55-7.50 (m, 2H), 7.46-7.41 (m, 2H), 
7.28-7.24 (m, 4H), 7.11 (app d, J = 7.8 Hz, 2H), 6.98 (app t, J = 7.0 Hz, 1H), 6.24-6.21 
(m, 1H), 6.15 (d, J = 3.1 Hz, 1H), 5.69 (d, J = 16.0 Hz, 2 H), 3.77 (s, 3H); 13C NMR (100 
MHz, CDCl3) δ 165.0, 150.6, 147.9, 142.2, 140.6, 136.5, 129.0, 128.8, 128.6, 128.1, 
122.6, 116.8, 110.1, 109.7, 79.2, 56.8, 52.1; FT-IR (thin film, cm-1) νmax 3031, 2951, 
1721 1597, 1492, 1247, 1014, 803, 735, 697; HRMS calc’d for C22H19NO4 [M+] 
361.1314 found 361.1318. 
             
(3R,6R)-methyl-3-isopropyl-2,6-diphenyl-3,6-dihydro-2H-1,2-
oxazine-4-carboxylate (2-8d): Following the general procedure, 
tetrahydro-1,2-oxazine 2-7d (121 mg, 0.29 mmol) and Pd2dba3 (16 mg, 
6 mol %) were brought to reflux in CH3CN (5 mL) for 3 h. Filtration and purification 
(silica gel column chromatography, EtOAc/hexanes 2, 4, 10%) provided dihydro-1,2-
oxazine 2-8d (70%, 67 mg, 0.20 mmol) as a yellow oil; Rf = 0.50 (30% EtOAc/hexanes); 
1H NMR (400 MHz, CDCl3) δ 7.42-7.37 (m, 5H), 7.35-7.30 (m, 2H), 7.11 (app d, J = 7.8 
Hz, 2H), 6.96 (app t, J = 7.4 Hz, 1H), 6.87 (d, J = 2.0 Hz, 1H), 5.33 (t, J = 2.3, 1H), 4.33 
(dd, J = 7.0, 2.4 Hz, 1H), 3.82 (s, 3H), 2.39 (m, J = 7.0 Hz, 1H), 1.14 (d, J = 6.6 Hz, 3H), 
1.04 (d, J = 7.0 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 166.5, 147.9, 137.7, 136.4, 
131.3, 129.4, 129.0, 128.8, 128.4, 121.4, 115.9, 73.0, 59.4, 52.1, 33.0, 20.9, 19.8; FT-IR 
(thin film, cm-1) νmax 2959, 2360, 1718, 1596, 1491, 1246, 1089, 745, 695; HRMS calc’d 
for C21H23NO3 [M+] 337.1678, found 337.1673. 
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Methyl-3-(4-nitrophenyl)-2,6-diphenyl-3,6-dihydro-2H-1,2-
oxazine-4-carboxylate (2-8e): Following the general procedure, 
tetrahydro-1,2-oxazine 2-7e (92 mg, 0.18 mmol) and Pd2dba3 (10 mg, 
6 mol %) were brought to reflux in CH3CN (5 mL) for 3 h. Filtration and purification 
(silica gel column chromatography, EtOAc/hexanes 2, 4, 10%) provided dihydro-1,2-
oxazine 2-8e (79%, 60 mg, 0.14 mmol) as a yellow powder; Rf = 0.36 (30% 
EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 8.03 (d, J = Hz, 2H), 7.52−7.43 (m, 
8H), 7.21 (t, J = Hz, 2H), 7.01 (d, J = Hz, 2H), 6.93 (t, J = Hz, 1H), 5.78 (s, 1H), 5.63 (s, 
1H), 3.73 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 182.9, 175.3, 164.8, 147.4, 145.1, 
144.1, 140.8, 136.1, 130.3, 129.2, 129.1, 128.8, 127.8, 122.9, 116.8, 78.9, 62.6, 52.5; FT-
IR (thin film, cm-1) νmax 3033, 2951, 2361, 2340, 1717, 1596, 1520, 1492, 1454, 1437, 
1347, 1247, 1108, 1078, 909, 833, 754, 736, 698; HRMS calc’d for C24H20N2O5 [M+] 
416.1372, found 416.1367. 
             
Methyl-3-(4-methoxyphenyl)-6-phenyl-2-(p-tolyl)-3,6-dihydro-
2H-1,2-oxazine-4-carboxylate (2-8f): Following the general 
procedure, tetrahydro-1,2-oxazine 2-7f (56 mg, 0.11 mmol) and Pd2dba3 (6.2 mg, 6 mol 
%) were brought to reflux in CH3CN (5 mL) for 3 h. Filtration and purification (silica gel 
column chromatography, EtOAc/hexanes 2, 4, 10%) provided dihydro-1,2-oxazine 2-8f 
(79%, 37 mg, 0.09 mmol) as a white powder; Rf = 0.41 (30% EtOAc/hexanes); 1H NMR 
(400 MHz, CDCl3) δ 7.53−7.50 (m, 2H), 7.48−7.39 (m, 3H), 7.31 (t, J = 1.2 Hz, 1H), 
7.23−7.19 (m, 2H), 7.00 (d, J = 8.2 Hz, 2H), 6.92−6.89 (m, 2H), 6.73−6.99 (m, 2H), 5.71 
(s, 1H), 5.47 (s, 1H), 3.72 (s, 3H), 3.71 (s, 3H), 2.24 (s, 3H); 13C NMR (100 MHz, 
CDCl3) δ 165.3, 159.0, 145.6, 139.4, 136.9, 131.5, 130.7, 129.1, 128.9, 128.8, 127.9, 
117.3, 113.1, 78.5, 62.6, 55.0, 52.0, 20.7; FT-IR (thin film) νmax 3031, 2951, 2836, 1719, 
1609, 1509, 1455, 1437, 1245, 1177, 1107, 1033, 908, 820, 733, 699, 648, 607; HRMS 
calc’d for C26H25NO4 [M+] 415.1784, found 415.1786. 
             
N
O
CO2MeO2N
N
O
CO2MeMeO
46 
 
(3R,6S)-methyl-6-ethyl-2,3-diphenyl-3,6-dihydro-2H-1,2-oxazine-4-
carboxylate (2-8g): Following the general procedure, tetrahydro-1,2-
oxazine 2-7g (74 mg, 0.18 mmol) and Pd2dba3 (10 mg, 6 mol %) were 
brought to reflux in CH3CN (5 mL) for 3 h. Filtration and purification (silica gel column 
chromatography, EtOAc/hexanes 2, 4, 10%) provided dihydro-1,2-oxazine 2-8g (85%, 49 
mg, 0.15 mmol) as a yellow oil; Rf = 0.50 (30% EtOAc/hexanes); 1H NMR (400 MHz, 
CDCl3) δ 7.25-7.15 (m, 9H), 7.01 (app d, J = 7.8 Hz, 2H), 6.89 (app t, J = 7.0 Hz, 1H), 
5.48 (s, 1H), 4.65 (t,  J = 6.3 Hz, 1H), 3.70 (s, 3H), 1.93-1.84 (m, 2H), 1.19 (t, J = 7.4 Hz, 
3H); 13C NMR (100 MHz, CDCl3) δ 165.2, 148.1, 140.4, 136.3, 130.7, 130.0, 129.6, 
128.5, 127.6 (x2), 122.0, 116.8, 63.1, 51.9, 26.1, 10.1; FT-IR (thin film, cm-1) νmax 2967, 
2360, 1720, 1597, 1492, 1453, 1244, 1077, 755, 697; HRMS calc’d for C20H21NO3 [M+] 
323.1521, found 323.1521. 
             
(3S,6S)-methyl-6-ethyl-3-(furan-2-yl)-2-phenyl-3,6-dihydro-2H-1,2-
oxazine-4-carboxylate (2-8h): Following the general procedure, 
tetrahydro-1,2-oxazine 2-7h ( mg,  mmol) and Pd2dba3 (mg, 6 mol %) 
were brought to reflux in CH3CN (5 mL) for 3 h. Filtration and purification (silica gel 
column chromatography, EtOAc/hexanes 2, 4, 10%) provided dihydro-1,2-oxazine 2-8h 
(%,  mg, mmol) as a yellow oil; Rf = 0xx (30% EtOAc/hexanes); 1H NMR (400 MHz, 
CDCl3) δ; 13C NMR (100 MHz, CDCl3) δ; FT-IR (thin film, cm-1) νmax; HRMS calc’d 
for C18H19NO4 [M+] 313.1314 found . 
             
2.4.5 Synthesis of Pyrroles 
General Method: One pot synthesis; 
To a solution of tetrahydro-1,2-oxazine (1 mmol) in CH3CN (5 mL) was added Pd2dba3 
(6 mol %). The solution was placed under Ar and brought to reflux (80 °C) for 3 h. At 
this time, the reaction was cooled to 40 °C and either NEt3 or DBU (3 equiv) was added 
in one portion, and the reaction was stirred further for the time indicated. Upon 
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completion (TLC analysis), the solution was filtered through celite and the solvent was 
removed under reduced pressure. Purification of the residue by column chromatography 
(silica gel, EtOAc/hexanes) gave the desired pyrroles. 
Note: for compounds that co-elute with dba (dibenzylideneacetone ligand) (compounds 
2-12a-c, f, g) the following work-up procedure was used: the reaction residue was 
dissolved in MeOH (3 mL) and NaBH4 (1.2 equiv/ mmol dba) was slowly added. After 
dba reduction (as based on TLC analysis), the mixture  the organics were collected via 
extraction with Et2O. The extract was absorbed onto silca and the solvent was removed 
by reduced pressure. Purification was then effected by the above methods. 
             
Methyl-1,2,5-triphenyl-1H-pyrrole-3-carboxylate (2-12a): Following 
general method A, dihydro-1,2-oxazine 2-8a (38 mg, 0.10 mmol) and 
DBU (45 µL, 0.30 mmol) in CH3CN (4 mL, 25 °C, 5 min) gave 2-12a 
(79%, 28 mg, 0.079 mmol).  Following general method B (one-pot procedure), 
tetrahydro-1,2-oxazine 2-7a (57 mg, 0.12 mmol), Pd2dba3 (7 mg, 0.0072 mmol) in 
CH3CN (5 mL, 80 °C, 3 h), followed by DBU (54 µL, 0.36 mmol) at room temperature (5 
min) gave 2-12a (76%, 28 mg, 0.080 mmol) as a white powder; Rf = 0.45 (30% 
EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.25−7.12 (m, 11H), 7.11−7.07 (m, 2H), 
6.95 (s, 1H), 6.94−6.91 (m, 2H), 3.73 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 165.1, 
139.9, 137.8, 134.7, 132.1, 131.4, 131.2, 128.8, 128.6, 128.5, 128.0, 127.8, 127.6, 127.2, 
126.8, 113.8, 110.8, 51.0; FT-IR (thin film, cm-1) νmax 3061, 2948, 2360, 2251, 1714, 
1599, 1559, 1496, 1474, 1439, 1404, 1274, 1223, 1183, 1113, 912, 777, 760, 731, 696, 
542; HRMS calc’d for C24H19NO2 [M+] 353.1416, found 353.1424. 
             
(E)-methyl-1,5-diphenyl-2-styryl-1H-pyrrole-3-carboxylate (2-
12b): Following general method B tetrahydro-1,2-oxazine 2-7b (68 
mg, 0.14 mmol), Pd2dba3 (7.5 mg, 0.008 mmol) in CH3CN (5 mL, 
80 °C, 3 h), followed by DBU (57 µL, 0.41 mmol) at room temperature (5 min) gave 2-
N
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12b (79%, 42 mg, 0.10 mmol) as a yellow powder; Rf = 0.53 (30% EtOAc/hexanes); 1H 
NMR (400 MHz, CDCl3) δ 7.54 (d, J = 16.8 Hz, 1H), 7.45−7.38 (m, 3H), 7.28−7.20 (m, 
7H), 7.20−7.15 (m, 4H), 7.10−7.04 (m, 2H), 6.90 (s, 1H), 6.40 (d, J = 17.2 Hz, 1H), 3.90 
(s, 3H); 13C NMR (100 MHz, CDCl3) δ 165.5, 138.6, 137.5, 136.4, 136.0, 132.5, 131.8, 
128.3, 129.1, 128.7, 128.6, 128.5, 128.0, 127.6, 127.0, 126.4, 117.0, 114.4, 111.9, 51.2, 
27.3; FT-IR (thin film, cm-1) νmax 3059, 2947, 2360, 2339, 1701, 1652, 1597, 1494, 
1473, 1449, 1275, 1244, 1212, 1090, 1071, 969, 759, 695; HRMS calc’d for C26H21NO2 
[M+] 379.1572, found 379.1576. 
             
Methyl-2-(furan-2-yl)-1,5-diphenyl-1H-pyrrole-3-carboxylate (2-
12c): Following general method B tetrahydro-1,2-oxazine 2-7c (150 
mg, 0.32 mmol), Pd2dba3 (18 mg, 0.019 mmol) in CH3CN (5 mL, 80 °C, 
3 h), followed by DBU (140 µL, 0.96 mmol) at room temperature (5 min) gave 2-12c 
(69%, 64 mg, 0.19 mmol) as a white powder; Rf = 0.40 (30% EtOAc/hexanes); 1H NMR 
(400 MHz, CDCl3) δ 7.33 (s, 1H), 7.29−7.21 (m, 3H), 7.20−7.16 (m, 3H), 7.12−7.03 (m, 
4H), 6.92 (s, 1H), 6.36 (d, J = 3.5 Hz, 1H), 6.34−6.31 (m, 1H), 3.80 (s, 3H); 13C NMR 
(100 MHz, CDCl3) δ 164.6, 142.7, 138.2, 135.9, 131.8, 129.2, 128.7, 128.6, 128.2, 128.0, 
127.9, 127.1, 116.2, 113.1, 111.1, 110.6, 51.2; FT-IR (thin film) νmax 2948, 2361, 1715, 
1598, 1498, 1465, 1272, 1227, 1190, 1115, 1074, 1005, 898, 821, 760, 698, 595, 554; 
HRMS calc’d for C22H17NO3 [M+] 343.1208, found 343.1209. 
             
Methyl-2-(4-nitrophenyl)-1,5-diphenyl-1H-pyrrole-3-
carboxylate (2-12d): Following general method A, dihydro-1,2-
oxazine 2-8e (12 mg, 0.03 mmol) and DBU (13 µL, 0.09 mmol) in 
CH3CN (5 mL, 25 °C, 5 min) gave 2-12d (95%, 11.4 mg, 0.028 mmol).  Following 
general method B tetrahydro-1,2-oxazine 2-7e (68 mg, 0.14 mmol), Pd2dba3 (7.5 mg, 
0.008 mmol) in CH3CN (5 mL, 80 °C, 3 h), followed by NEt3 (57 µL, 0.41 mmol) at 
room temperature (24 h) gave 2-12d (79%, 42 mg, 0.10 mmol) as a yellow powder; Rf = 
0.42 (30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 8.08−8.05 (m, 2H), 
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7.38−7.35 (m, 2H), 7.25−7.17 (m, 6H), 7.10−7.06 (m, 2H), 6.96 (s, 1H), 6.93−6.90 (m, 
2H), 3.75 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 164.7, 147.0, 138.3, 137.2, 136.7, 
136.1, 132.2, 131.5, 129.0, 128.7, 128.6, 128.3, 128.1, 127.3, 122.5, 114.9, 111.3, 51.2; 
FT-IR (thin film, cm-1) νmax 2949, 2361, 2340, 1712, 1600, 1559, 1518, 1473, 1345, 
1275, 1224, 1184, 1114, 855, 757, 727, 698; HRMS calc’d for C24H18N2O4 [M+] 
398.1267, found 398.1276. 
             
Methyl-2-(4-methoxyphenyl)-5-phenyl-1-(p-tolyl)-1H-pyrrole-
3-carboxylate (2-12e): Following general method A, dihydro-1,2-
oxazine 2-8f (50 mg, 0.12 mmol) and DBU (54 µL, 0.36 mmol) in 
CH3CN (4 mL, 25 °C,  5 min) gave 2-12e (98%, 47 mg, 0.12 mmol).  Following general 
method B tetrahydro-1,2-oxazine 2-7f (100 mg, 0.20 mmol), Pd2dba3 (11 mg, 0.011 
mmol) in CH3CN (5 mL, 80 °C, 3 h), followed by DBU (90 µL, 0.60 mmol) at room 
temperature (5 min) gave 2-12e (95%, 75 mg, 0.11 mmol) as a white powder; Rf = 0.37 
(30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.22−7.15 (m, 2H), 7.12 (t, J = 
2.0 Hz, 1H), 7.11−7.06 (m, 3H), 6.95 (d, J = 8.2 Hz, 2H), 6.89 (s, 1H), 6.82−6.73 (m, 
4H), 3.77 (s, 3H), 3.73 (s, 3H), 2.26 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 165.2, 
159.0, 140.0, 137.3, 135.3, 134.5, 132.4, 132.3, 129.2, 128.6, 128.5, 128.0, 126.7, 123.7, 
113.4, 112.8, 110.6, 55.1, 50.9, 21.0; FT-IR (thin film, cm-1) νmax 2948, 2834, 1715, 
1611, 1559, 1514, 1497, 1437, 1290, 1248, 1221, 1177, 1109, 1037, 839, 761, 735, 698, 
534; HRMS calc’d for C26H23NO3 [M+] 397.1678, found 397.1668. 
             
Methyl-5-ethyl-1,2-diphenyl-1H-pyrrole-3-carboxylate (2-12f): 
Following general method B tetrahydro-1,2-oxazine 2-7g (63 mg, 0.16 
mmol), Pd2dba3 (8.5 mg, 0.009 mmol) in CH3CN (5 mL, 80 °C, 3 h), 
followed by DBU (70 µL, 0.47 mmol) at 40 °C (24 h) gave 2-12f (73%, 
34 mg, 0.11 mmol) as a white powder; Rf = 0.47 (30% EtOAc/hexanes); 1H NMR (400 
MHz, CDCl3) δ 7.30−7.24 (m, 3H), 7.18−7.14 (m, 5H), 7.07−7.02 (m, 2H), 6.56 (s, 1H), 
3.69 (s, 3H), 2.39 (q, J = 7.4 Hz, 2H), 1.16 (t, J = 7.4 Hz, 2H); 13C NMR (100 MHz, 
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CDCl3) δ 165.3, 139.7, 137.8, 136.6, 131.6, 131.0, 128.8, 128.6, 127.9, 127.5, 127.2, 
106.9, 50.8, 20.3, 12.7; FT-IR (thin film, cm-1) νmax 3061, 2969, 2946, 1712, 1597, 1529, 
1497, 1484, 1436, 1412, 1237, 1218, 1146, 1114, 1010, 940, 914, 819, 763, 697; HRMS 
calc’d for C20H19NO2 [M+] 305.1416, found 305.1414. 
             
Methyl-5-ethyl-2-(furan-2-yl)-1-phenyl-1H-pyrrole-3-carboxylate (2-
12g): Following general method B tetrahydro-1,2-oxazine 2-7h (54 mg, 
0.14 mmol), Pd2dba3 (7.4 mg, 0.008 mmol) in CH3CN (5 mL, 80 °C, 3 h), 
followed by DBU (61 µL, 0.41 mmol) at 40 °C (24 h) gave 2-12g (50%, 20 mg, 0.07 
mmol) as a white powder; Rf = 0.43 (30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) 
δ 7.36−7.32 (m, 3H), 7.23 (d, J = 1.8 Hz, 1H), 7.18−7.11 (m, 2H), 6.54 (s, 1H), 6.33 (d, J 
= 3.5 Hz, 1H), 6.29−6.24 (m, 1H), 3.77 (s, 3H), 2.37 (q, J = 8.2 Hz, 2H), 1.14 (t, J = 7.6 
Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 164.9, 144.3, 142.2, 138.1, 137.7, 128.8, 128.2, 
128.0, 127.8, 114.7, 112.2, 110.5, 107.4, 51.1, 20.1, 12.7; FT-IR (thin film, cm-1) νmax 
2970, 2360, 1711, 1598, 1517, 1498, 1469, 1375, 1242, 1225, 1162, 1117, 1006, 898, 
821, 771, 738, 698, 595; HRMS calc’d for C22H17NO3 [M+] 295.1208,  found 295.1203. 
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3 Synthetic Studies Towards BM 212 and Atorvastatin 
Calcium (Lipitor®) 
3.1 Introduction 
3.1.1 BM 212 
In order to highlight the utility of the methodology outlined in Chapter 2, it was applied 
to the attempted total syntheses of both BM 212, an antimycobacterial drug, and Lipitor® 
(Figure 3.1). 
 
Figure 3.1 Chemical structures of BM 212 and Lipitor® 
BM 212 was originally synthesized in response to the increasing number of multidrug 
resistant strains of Mycobaterium tuberculosis. With the aim of finding new drugs 
capable of combating tuberculosis, BM 212 was endowed with potent and highly 
selective antimycobacterial properties.1 BM 212 has shown more potent activity than that 
of commonly used drugs to combat tuberculosis.2 Its current commercial synthesis as 
described in the patent can be seen in Scheme 3.1.3 
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Scheme 3.1 Commercial synthesis of BM 212 
Although the patent does not go into any detail regarding the experimental procedures 
involved in the synthesis of BM 212, the first step is a Stetter reaction between methyl 
vinyl ketone and p-chlorobenzaldehyde. The Stetter reaction affords the iconic 1, 4-
diketone structure (3-3) needed to undergo a Paal-Knorr pyrrole synthesis with p-
chloroaniline. Finally condensation of N-methypiperazine onto formaldehyde followed 
by an electrophillic aromatic substitution reaction completes BM 212. 
The great success of BM 212 sparked the construction and search for new diaryl pyrroles 
in order to achieve even higher biological activity.3 This simple molecule is gradually 
elevating its status from a small di-aryl pyrrole to a compound that could revolutionize 
the fight against tuberculosis. 
3.1.2 Atorvastatin Calcium (Lipitor®) 
Lipitor® is a member of the drug class called statins. Statins act to block an enzyme in the 
liver, HMG-CoA reductase. This enzyme is responsible for cholesterol synthesis in the 
body. Lipitor® is clinically proven to lower unwanted cholesterol by 40-60 % based on 
dosage. Lipitor® was first synthesized in 1985 by Bruce Roth at Pfizer and it is 
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considered to be the most successful drug in pharmaceutical history. Since its approval in 
1996 Lipitor® generated on average  US $13 billion in profit annually.4  
The original synthesis by Roth involved the convergence of a cyano side chain (3-8) with 
a 1,4-diketone (3-7). By effectively reducing the cyano group and carrying out a Paal-
Knorr pyrrole synthesis between the two components he was able to synthesize Lipitor® 
asymmetrically and efficiently enough for industrial processing. The convergent 
approach and synthesis of the 1,4-diketone subunit can be seen in Scheme 3.2.5 The first 
major intermediate 3-7 was synthesized in two steps starting with isobutyrylacetanilide 
(3-9). First a Knovenagle condensation between 3-9 and benzaldehyde afforded 3-10. 
Next a Stetter reaction between p-fluorobenzaldehyde and 3-10 affords 3-7 in an overall 
68 % yield. 
 
Scheme 3.2 Convergent approach and synthesis of 1,4-diketone 
Roth chose to synthesize the cyano side chain intermediate 3-8 in three separate ways. 
Each synthesis was done successfully in minimal synthetic steps and could be scaled up 
to multi kilogram levels. The three separate syntheses can be seen in Scheme 3.3.6 
55 
 
 
Scheme 3.3 Syntheses of side chain 
As you can see in Scheme 3.3 each synthesis starts from a commercially available 
advanced intermediate. The first synthesis begins with a CDI coupling between ester 3-11 
and oxanion 3-12 producing 3-13. 3-13 is then stereoselectively reduced and acetylated 
affording the desired intermediate 3-8. The second synthesis differentiates from the first 
only in the first step. It is initiated with a Claisen condensation between the commercially 
available alcohol 3-15 and ester 3-16. This produces a common intermediate (3-13) 
which is carried forward identically to the first synthesis. The final synthesis is 
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considerably shorter than the other two. In the third synthesis alcohol 3-17 is derivatized 
and then displaced with cyanide affording the desired intermediate 3-8. 
The stage was now set for Roth to complete the synthesis of Lipitor®. The cyano group 
was reduced with raney nickel under an atmosphere of H2 affording the necessary amine 
(3-19) for the putative Paal-Knorr pyrrole synthesis. After some considerable tweaking 
Roth found the required conditions to effectively promote the pyrrole formation. 
Cleavage of the acetyl and saponification of the tBu ester affords the carboxylic acid form 
of Lipitor® (Scheme 3.4).5 
 
Scheme 3.4 Completion of Lipitor® 
3.2 Results and Discussion 
3.2.1 Retrosynthesis of BM 212 
As seen in figure 3.1 BM 212 has the exact one, two, three, five substitution pattern that 
was obtained from the methodology reported in Chapter 2. The only minute difference 
being that instead of having a methyl ester at the three position there is a substituted 
piperazine ring which could easily be installed in the final stages of the synthesis. The 
proposed retrosynthetic outline can be seen in Figure 3.2. 
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Figure 3.2 Proposed retrosynthesis for BM 212 
As illustrated in the retrosynthesis it was envisioned that the methyl substituted 
piperazine could be attached by performing an SN2 substitution reaction on the terminally 
mesylated alcohol (3-21) with 1-methylpiperazine. 3-21 would come from an LAH 
reduction of the methyl ester on the parent pyrrole ring (3-22). The pyrrole could be 
formed using the aforementioned conditions, in Chapter 2, from tetrahydro-1,2-oxazine 
3-23. 3-23 could be formed from a three component coupling between p-
chlorophenylhydroxylamine, acetaldehyde and 1-allyl-1-methyl-2-(4-
chlorophenyl)cyclopropane-1,1-dicarboxylate. 
3.2.2 Synthesis of the Required Cyclopropane and Hydroxylamine 
Of the material required for the [3+3] cycloaddition both the hydroxylamine (3-24) and 
1-allyl-1-methyl-2-(4-chlorophenyl)cyclopropane-1,1-dicarboxylate (3-26) needed to be 
synthesized. 3-26 was made in four steps from commercially available material, 
beginning with a Knoevenagle condensation between dimethyl malonate and p-
chlorobenzaldehyde. Followed by a Corey-Chaykovsky cyclopropanation of 3-28 
afforded 3-30 (Scheme 3.5).7,8  
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Scheme 3.5 Preparation of geminal 1,1-dimetyl-2-(4-chlorophenyl)cyclopropane-1,1-
dicarboxylate 
The mono-allylated cyclopropane (3-26) can be obtained from the diester cyclopropane 
(3-30) via the standard mono-allylation procedure mentioned in chapter 2, with one slight 
modification. Instead of a 1:1, H2O:MeOH solvent, a 1:1:1 solvent mixture of 
H2O:THF:MeOH was used. This was altered because the solubility of 3-30 was poor in 
the standard H2O:MeOH solvent. Treatment of the cyclopropane ester acid with allyl 
bromide in DMF in the presence of K2CO3 produced the desired cyclopropane in an 
overall 87 % yield over the final two steps (Scheme 3.6).9 
 
Scheme 3.6 Preparation of 1-allyl-1-methyl-2-(4-chlorophenyl)cyclopropane-1,1-
dicarboxylate 
The general procedure for the synthesis of aryl hydroxylamines is the reduction of the 
correspond nitro compounds using a Zn dust suspension in H2O with NH4Cl.10 This 
seemed to be a suitable starting point for the formation of p-chlorophenylhydroxylamine 
(3-33). Upon subjecting p-chloronitrobenzene to the outlined reducing conditions only 
the fully reduced aniline species was obtained (Scheme 3.7). 
 
Scheme 3.7 Preparation of p-chlorophenylhydroxylamine 
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After successive failures using the generic procedures it was concluded that the 
conditions would not be adequate for the desired conversion. Continuing forwards and 
hoping that perhaps adjusting the reaction time or reducing the equivalents of Zn would 
allow for partial reduction. The reaction was repeated under the same reducing conditions 
while varying the timeframe or amount of Zn. Regrettably, each successive attempt failed 
to produce the hydroxylamine forcing us to revisit the literature in order to revise the 
synthesis. To our delight, a recent paper described the synthesis of the exact 
hydroxylamine from the parent nitro compound using an excess of Zn and NH4HCO2 in 
CH3CN under sonicating conditions as seen in Scheme 3.8.11 
 
Scheme 3.8 Formation of p-chlorophenylhydroxylamine 
Regardless of reaction times 3-24 was never solely formed. With shorter reaction times a 
mixture of starting material and product was continuously isolated. Prolonged reaction 
times resulted in a three component mixture containing starting material, the 
hydroxylamine and aniline species. In the interest of ease of separation a lower reaction 
time was chosen to minimize the number of compounds needed to be separated by flash 
column chromatography. 
3.2.3 Investigation of the [3+3] Cycloaddition Towards BM 212 
With all three of the necessary components in hand it was time to attempt formation of 
the substituted tetrahydro-1,2-oxazine, precursor to BM 212 (Scheme 3.9). 
 
Scheme 3.9 Three component coupling reaction for BM 212 
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As per usual nitrone formation was attempted in-situ for 30 minutes prior to adding the 
cyclopropane. While monitoring the reaction it was discovered that under the standard 
timeline the nitrone was unable to form. This is not unexpected as there was some 
precedence for this in Chapter 2 when using isobutraldehyde. Aliphatic aldehydes react 
much slower in nitrone formation than aryl aldehydes. Furthermore the high volatility of 
acetaldehyde substantially decreased the amount dissolved in the solution at any one time 
further impeding nitrone formation by limiting the possibility of a constructive collision 
occurring. To circumvent this problem the reaction was repeated with a significant excess 
(10 equivalents) of acetaldehyde and nitrone formation was monitored by the 
disappearance of p-chlorophenylhydroxylamine by TLC. Surprisingly no nitrone 
formation took place when an excess of acetaldehyde was used. Sadly prolonged reaction 
times at room temperature led to the decomposition of the 3-24. Once again the lack of 
nitrone formation was attributed to the combination of high volatility and decreased 
reactivity of acetaldehyde. To prevail over acetaldehyde’s low boiling point the reaction 
flask was cooled to 0 °C in hopes that the high concentration of dissolved acetaldehyde 
would surmount the possibility of attenuating the reaction rate. At 0 °C hydroxylamine 
decomposition had also halted and all the components necessary for the reaction to occur 
were now present and stable in solution. Yet again however nitrone formation failed to 
take place even with prolonged reaction times. These results were not discouraging; it 
was still believed that this reaction could be carried out successfully. Whether the 
reaction required a different Lewis acid or heating in a sealed tube; reaction conditions 
could be tailored to optimally promote the reaction. Table 3.1 shows the conditions 
attempted for the in-situ formation of the nitrone and their specific results. 
 
 
 
 
61 
 
 
Table 3.1 Various conditions used with acetaldehyde 
Equiv. of 
Hydroxylamine 
Equiv. of 
Aldeyhyde 
Conditions Result 
1.3 1.4 Yb(OTf)3, RT, 30 min No nitrone formation 
1.3 1.4 Yb(OTf)3, RT, 2 h Decomposition of 
hydroxylamine 
1.3 1.4 Yb(OTf)3, 0 °C, 2 h No nitrone formation 
1.3 2 Yb(OTf)3, 0 °C, 2 h No nitrone formation 
3 10 Yb(OTf)3, 0 °C, 2 h No nitrone formation 
3 10 Yb(OTf)3, 60 °C, 2 h Decomposition of 
hydroxylamine 
3 10 Sc(OTf)3, 0 °C, 2 h No nitrone formation 
3 10 Yb(OTf)3, 110 °C,  
2 h, sealed tube 
Decomposition of 
hydroxylamine 
The equivalents of the hydroxylamine and aldehyde are compared to that of the cyclopropane (1equiv.). The catalyst loading was 10 
mol %. 
It was at this point that conclusions were drawn and perhaps forming the tetrahydro-1,2-
oxazine required for BM 212 via the three component coupling method was not going to 
occur. In every case investigated no nitrone formation occurred before the hydroxylamine 
began to decompose. Once again this is due to the diminished reactivity of aliphatic 
aldehydes to nitrone formation and their inability to stabilize a partial positive charge. 
In a final effort to synthesize 3-26 for BM 212 a more reactive masked version of 
acetaldehyde was employed. In this case the three component coupling reaction was 
carried out with chloral hydrate in place of acetaldehyde. The dehydrating conditions of 
the reaction should be sufficient enough to generate the reactive aldehyde in-situ. The 
resulting trichloromethyl group could then be reduced using Zn in the presence of AcOH 
affording the desired tetrahydro-1,2-oxazine. The sequence of reactions proposed for this 
method can be seen in Scheme 3.10. 
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Scheme 3.10 Three component coupling with masked aldehyde 
As has been the trend with BM 212 all attempted reactions with chloral hydrate failed 
regardless of the conditions used. If the solution was cooled no nitrone formation would 
occur and if the solution was heated the hydroxylamine would decompose prior to 
reacting. It was at this point we concluded that perhaps BM 212 is not accessible by this 
methodology due to the lack of reactivity of acetaldehyde. All experimental inquiries 
towards BM 212 via this route were ceased and all focus turned towards Lipitor® which 
contained an aliphatic iPr group which was previously shown to be compatible with the 
[3+3] cycloaddition reaction. 
3.2.4 Retrosynthesis of Lipitor® 
The retrosynthetic outline for Lipitor® can be seen in Figure 3.3. The sequence itself is 
linear in nature but this is due to the fact that after the initial three component coupling 
reaction only two functional groups needed to be manipulated in order to produce the 
final PMP-protected pyrrole. 
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Figure 3.3 Retrosynthetic outline for Lipitor 
As outlined in the retrosynthesis the synthetic strategy culminates with the deprotection 
of the tertiary pyrrole amine followed by a substitution reaction on a diastereomerically 
pure statin side chain. The free N-H pyrrole would come from the deprotection of the 
penta-substituted pyrrole ring 3-37. The phenyl ring at the four position could be installed 
through a Suzuki coupling with phenyl boronic acid and 3-38. Prior to the Suzuki 
reaction the four position of the pyrrole will be brominated with NBS. The pendant amide 
will be formed through a coupling reaction between aniline and the acid of 3-39. This 
would all come from the tetra substituted pyrrole ring, 3-39, afforded from the cascade 
tandem dehydrocarbonylation, elimination and ring contraction reaction of 3-40. The 
starting materials required for 3-40 are cyclopropane 3-43 isobutraldehyde (3-42) and 
hydrolxylamine 3-41. 
3.2.5 Investigations Towards the Total Synthesis of Lipitor® 
The required fluorinated cyclopropane was made from the same sequence of reactions as 
the previous ones had been. Begining with a Knoevenagle condensation between p-
flurobenzaldehdye and dimethylmalonate, followed by a Corey-Chaykosvky 
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cyclopropanation. The resultant cyclopropane 3-45 was then allylated using the previous 
procedure; the series of reactions can be seen in Scheme 3.11.7,9 
 
Scheme 3.11 Preparation of 1-allyl-1-methyl-2-(4-fluorophenyl)cyclopropane-1,1-
dicarboxylate 
The next undertaking which was anticipated to be trivial was the formation of PMP-
hydroxylamine. A PMP group was chosen as the protecting group because there is a great 
deal of literature precedence for the removal of PMP groups from aromatic nitrogen 
atoms using CAN. Also electron rich aryl hydroxylamines work well with both the [3+3] 
annulation and pyrrole formation. However upon embarking down the published 
synthetic route it was quickly discovered how complicated the synthesis of such a small 
molecule can be. It has been previously reported that the hydroxylamine could be formed 
from p-methoxynitrobenzene using Zn and NH4Cl. The original literature source 
described an elaborate separation technique to remove the two major impurities, the 
aniline species and starting material. However each time the reaction was carried out 
regardless of how close or meticulous conditions were to matching the literature prep the 
desired hydroxylamine was never isolated. The only products ever isolated were the over 
reduced product or starting material (Scheme 3.12).12 
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Scheme 3.12 Preparation of PMP-hydroxylamine 
After successive failures with the literature procedure, 3-50 was subjected to the 
sonicating conditions used to synthesize p-chlorophenylhydroxylamine (3-24). Under 
sonicating conditions no product was obtained and only complete reduction took place. 
At what seemed like an impasse some helpful insight by a colleague brought to our 
attention some older literature work that had not been previously know to us. Still using 
Zn as the reducing agent and NH4Cl as the proton source historically a vast number of 
hydroxylamine had been synthesized using a H2O/ EtOH solvent mixture (entries 5 and 
6).13 Switching to these conditions and using a crystallization, isolation method the 
desired hydroxylamine had finally been synthesized. Table 3.2 shows the variety of 
conditions used in attempted formation of 3-41, as well as the optimization of the 
working conditions. 
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Table 3.2 Various attempts at formation of PMP-hydroxylamine 
 Equiv. of 
Zn 
Equiv. of 
Ammonium Salt 
Conditions Result 
 
2 1.1 NH4Cl H2O, 25 °C, 
20 min 
Starting material, or over 
reduction 
 
4 10.0 NH4HCOO CH3CN, 30 °C, 
sonicating, 1 h 
Over reduction 
 
2 1.1 NH4HCOO CH3CN, 25 °C, 
sonicating, 30 min 
Over reduction 
 
2 1.1 NH4Cl Degassed H2O,  
 25 °C, 40 min 
Over reduction 
 
2 1.1 NH4Cl H2O:EtOH (1:1),  
25 °C, 15 min 
1:1 mixture of product and 
starting material 
 2 1.1 NH4HCOO H2O:EtOH (3:1), 
 25 °C, 15 min 
1:1 mixture of product and 
starting material 
 4 1.05 NH4Cl H2O:EtOH (1:1),  
25 °C, 25 minutes 
Optimized 60 % yield of 
pure product 
It is important to point out that hydroxylamine 3-41 was quite sensitive to ambient 
conditions. Prolonged exposure to atmosphere would oxidize 3-41 back to starting 
material (3-50). Also at room temperature 3-41 would decompose within a day. After 
synthesizing 3-41, it was quickly put under an atmosphere of Ar and placed in the −20 °C 
freezer for storage. 
Ultimately after some considerable amount of time all the starting materials had been 
synthesized in substantial quantities and the synthetic exploration our towards the total 
synthesis of Lipitor® could commence. 
The first step was the [3+3] cycloaddition reaction which proved to be so problematic 
with the necessary starting material that the entire project was nearly abandoned. Initial 
reactions were carried out by forming the nitrone in-situ from the hydroxlamine (3-41). 
The general reaction schematic can be seen in Scheme 3.13.14 
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Scheme 3.13 Three component coupling reaction for Lipitor® 
Tetrahydro-1,2-oxazine formation (Scheme 3.13) did not go as planned and it was clear 
that some of the same problems previously encountered with BM 212 were going to 
occur here. PMP-hydroxylamine is prone to both chemical decomposition and oxidation. 
Even under the anhydrous conditions that the reaction was carried out in the 
hydroxylamine would rapidly decompose or oxidize to the nitro compound, making the 
in-situ nitrone formation extremely difficult, if possible at all. A wide variety of 
conditions were tried to generate the nitrone and they have been summarized in Table 
3.3. 
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Table 3.3 Attempted formation of the Lipitor® tetrahhydro-1,2-oxazine 
Equiv. of 
Hydroxylamine 
Equiv. of 
Aldeyhyde 
Temperature Catalyst Result 
1.3 1.4 25 °C Yb(OTf)3 Decomposition of 
hydroxylamine 
1.3 1.4 0 °C Yb(OTf)3 Decomposition of 
hydroxylamine 
1.3 1.4 0 °C None Decomposition of 
hydroxylamine 
1.3 1.4 25 °C Sc(OTf)3 Decomposition of 
hydroxylamine 
2 2.2 60 °C 15 mol % 
Sc(OTf)3 
Decomposition of 
hydroxylamine 
3 10 25 °C 15 mol % 
Sc(OTf)3 
 
Decomposition of 
hydroxylamine 
*The equivalents of the hydroxylamine and aldehyde are compared to that of the cyclopropane (1equiv). The catalyst loading was 10 
mol % unless otherwise stated. 
Similar to BM 212 the aldehyde was slow to react with the hydroxylamine however 
unlike BM 212 the hydroxylamine is extremely unstable regardless of the conditions 
used. Hydroxylamine decomposition could not be avoided. At lower temperatures it was 
postulated that the hydroxylamine would last long enough to react with the aldehyde; 
while at higher temperatures and increased amounts of both reagents it was envisioned 
that some nitrone would form even if the majority of the hydroxylamine decomposed. 
Based on our experimental findings PMP-hydroxylamine is not compatible in the three 
component coupling with isobutyraldehyde as its partner. 
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Our general synthetic route towards Lipitor® remained unchanged. Either a different 
hydroxylamine protecting group was required in order to proceed or the nitrone needed to 
be formed separately.  To increase our chances of finding suitable substrates for 
isobutraldehyde both BOC hydroxylamine and the nitrone generate from PMP-
hydroxylamine and isobutyradehyde were synthesized simultaneously. BOC-
hydroxylamine was synthesized according to the literature prep and was carried forward 
in the desired three component coupling reaction (Scheme 3.14).15 
 
Scheme 3.14 Synthesis and application of BOC-hydroxylamine 
BOC-hydroxylamine was chosen because it satisfied the required conditions of the Tsuji 
reaction. With a BOC group the nitrogen lone pair would be delocalized decreasing its 
nucleophilicity. BOC-hydroxylamine however proved to be incompatible with the three 
component coupling reaction. It would rapidly decompose faster than PMP-
hydroxylamine. This is not surprising however because it is well documented that BOC 
groups are extremely labile under the mildest acidic conditions. Therefore the required 
Lewis acid was rapidly decomposing the hydroxylamine. This method was quickly 
discarded and our attention was refocused onto PMP-hydroxylamine. 
Nitrone formation was carried according to previously used conditions. 3-42 and 3-41 
were dissolved in anhydrous toluene in the presence of molecular sieves under Ar and 
stirred overnight (Scheme 3.15). 
 
Scheme 3.15 Nitrone formation 
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After the allotted time the reaction was filtered and the solvent was removed under 
reduced pressure keeping the water bath below 40 °C. The crude residue was dissolved in 
a minimal amount of hexanes and placed in the freezer for crystallization. Gratifyingly 
the nitrone precipitated out of solution as fine crystals overnight at −20 °C. 
With an optimal route to the nitrone (3-55) one complication that arose was the 
scalability of the two reactions required for nitrone formation. The largest mass of 
starting material to begin with when reducing the p-methoxynitrobenzene is 
approximately 5 g; anything above this amount consistently caused the yield to drop 
drastically. Even after extensive work towards optimizing the reaction only a maximum 
60 % yield was obtained for each individual step (nitro reduction and nitrone formation) 
resulting in a maximum 36 % overall yield of the nitrone. The low mass recovery of the 
desired compounds forced the synthesis of a large stock of the nitrone prior to continuing 
onward with the annulation reaction. 
At this point it was believed that the [3+3] cycloaddition could be facilitated with 
cyclopropane 3-43 and nitrone 3-55. The reason being that the nitrone was significantly 
more stable than the hydroxylamine precursor. Subjecting the starting material to the 
same conditions as the previous three component coupling reaction should theoretically 
generate some of the desired product. Tetrahydro-1,2-oxazine formation was carried out 
according to Scheme 3.16.16 
 
Scheme 3.16 Lipitor® tetrahydro-1,2-oxazine synthesis 
Inexplicably upon working up the above reaction the majority of the cyclopropane was 
recovered and all of the nitrone had decomposed. It was quite shocking to discover that 
even with the enhanced stability of the nitrone not even trace amounts of the tetrahydro-
1,2-oxazine was observed. Curious as to whether or not slightly altering the conditions 
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could promote product formation once again the Lewis acidity and temperature of the 
reaction were systematically altered. The assortment of conditions attempted to form 3-42 
and their individual results can be seen in Table 3.4. 
 
Table 3.4 Attempted formation of Lipitor® tetrahydro-1,2-oxazine 
Equiv. of 
Nitrone 
Catalyst Loading Temperature Result 
1.3 10 mol % Yb(OTf)3 RT Decomposition of nitrone 
1.3 10 mol % Yb(OTf)3 0 °C Decomposition of nitrone 
1.3 20 mol % Yb(OTf)3 60 °C Decomposition of nitrone 
2.6 20 mol % Yb(OTf)3 RT Decomposition of nitrone 
1.3 10 mol % Sc(OTf)3 RT Decomposition of nitrone 
1.3 10 mol % Sc(OTf)3 80 °C Decomposition of nitrone 
*The equivalents of the nitrone are compared to that of the cyclopropane (1equiv). 
Again regardless of the conditions no cycloaddition product was observed prior to 
decomposition of the nitrone. It was not anticipated that the cyclopropane would persist 
as long as it did under the elevated temperature and Lewis acidity. It has been shown that 
at approximately 80 °C under Lewis acidic systems the 1,1-dimethylcyclopropane-1,1-
dicaboxylates could open and reclose forming all potential diastereomers.17 It was curious 
then that  3-43 was being readily recovered almost in its entirety. It was postulated that 
no cycloadditon between 3-55 and 3-43 was occurring due to a lack of reactivity of the 
cyclopropane. Perhaps the p-fluorine substituent on the phenyl ring has such a drastic 
effect on the phenyl rings donor capability that it will not open under normal conditions. 
To investigate this theory we simultaneously scoured the literature looking for some 
precedence of the predictions and paralleled this by testing 3-43 with some of the most 
reactive species in the [3+3] cycloaddition. The test reaction can be seen in Scheme 3.17; 
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previous work has shown that both benzaldehyde and phenylhydroxylamine can cyclize 
with cyclopropanes rapidly and efficiently. 
 
Scheme 3.17 Test cycloaddition with cyclopropane 3-45 
In this case however when 3-43 was combined with the two afformentioned compounds 
(3-56, 3-57) after the same reaction time a significant amount of unreacted nitrone and 
cyclopropane was present. A 1H NMR experiment showed that in fact only 16 % of the 
starting cyclopropane had been converted to product. When you directly compare this 
result to previous examples it is unequivocally evident that the fluorine substitution is 
significantly attenuating the reaction under the current conditions. This conclusion was 
fortified when it was discovered that the result coincided with the information discovered 
in the literature.18 In general Lewis acids have shown success with dimethyl-2-(4-
fluorophenyl)cyclopropane-1,1-dicarboxylate however these Lewis acids are typically 
late transition metals or iodide containing salts. Using these newfound results and some 
past experiences by a former group member, Mike Ganton who showed that the homo 
[3+2] cycloaddition between a DA cyclopropane and a nitrone was effectively promoted 
with MgI2. A reaction was attempted using 10 mol % MgI2 in anhydrous toluene 
(Scheme 3.18).19 
 
Scheme 3.18 MgI2 promoted cycloaddition 
73 
 
This time fortunately the cycloaddition was successful providing the desired product in a 
10:1 disatereomeric ratio. Upon optimization of the reaction a maximum 60 % yield was 
achieved using 15 mol % catalyst and a reaction period of two days. The suboptimal yield 
was accredited to again the rapid decomposition of the nitrone. 
The next series of reactions, seen in Scheme 3.19, involved conversion of 3-42 to the 
pyrrole using the cascade Tsuji dehydrocarbonylation reaction, elimination and ring 
contraction sequence.20 The four position of 3-39 can be readily brominated with NBS 
and it proceeds rapidly with no side reactions. Next a Suzuki cross coupling between 
phenyl boronic acid and 3-58 afforded the fully functionalized pyrrole, 3-59.21 The next 
step in the synthesis was the saponification of the methyl ester to the acid which would 
allow for a functional group susceptible to amide formation. 
 
Scheme 3.19 Synthesis of fully functionalized pyrrole 
The saponification proved to be a non trivial reaction which took quite some time to 
overcome. The combination of the high steric demand and low solubility of 3-59 made it 
impossible to saponify under normal conditions. 3-60 was subjected to various quantities 
of 1.7 M NaOH in MeOH and it never fully dissolved or saponified the ester even at 
refluxing temperature regardless of how low the concentration of the pyrrole was. Table 
3.5 shows the multitude of unsuccessful reactions employed for saponification. 
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Table 3.5 Saponification Conditions 
Reagent Solvent Temperature Result 
1.7 M NaOH (1.2 equiv.) MeOH 25 °C Recovery of starting material 
1.7 M NaOH (50 equiv.) MeOH 100 °C Recovery of starting material 
4 M NaOH (50 equiv.) MeOH:THF 100 °C Recovery of starting material 
C3H9SiOK DCM 25 °C Recovery of starting material 
* See reference 22. 
It was decided that perhaps the saponification at such a late stage is not synthetically the 
best route due to the steric demand and lack of solubility of the substrate. Instead amide 
formation was attempted prior to the Suzuki coupling. Already aware that the pyrrole was 
going to require thermally harsh conditions to undergo saponification it was decided to 
start by refluxing 3-58 in copious amounts of MeOH with an equal volume of a 1.7 M 
NaOH (100 equiv.) solution (Scheme 3.20). This change in substrate proved effective in 
the formation of acid 3-61. 
 
Scheme 3.20 Successful saponification of 3-58 
After optimization of the reaction it was determined that the equivalents of NaOH could 
be reduced by half while maintaining the same temperature. The reaction also must reflux 
for a minimum of 20 hours; anything less would result in the isolation of a mixture of 
starting material and product. 
The next phase was the formation of the phenyl amide from the carboxcyclic acid. We 
opted to initiate the investigation with a DCC coupling; to that vein 3-61 was subjected to 
the coupling conditions described in Scheme 3.21.23,24 
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Scheme 3.21 DCC coupling 
At room temperature only starting material was recovered. The parent acid is sparingly 
soluble in Et2O thus in order to dissolve the pyrrole an abundant amount of Et2O was 
used. It is possible that the reaction was too dilute and the necessary reagents were not 
coming in proper contact to progress the reaction. Sterics is likely also a large factor in 
impeding the reaction. To surmount these postulated issues the solvent system was 
switched to THF and the reaction was conducted in the same manner but at reflux as seen 
in Scheme 3.22. 
 
Scheme 3.22 DCC coupling in refluxing THF 
In the above scheme the disappearance of starting material was observed by TLC analysis 
and a new significantly more non polar compound was gradually forming. This made us 
quite optimistic that the desired product had been formed. But upon isolation of the new 
compound it was discovered that product was not produced but instead a compound that 
looked like the DCC adduct of the starting material had been created (Figure 3.4). This 
conclusion was derived from the 1H NMR spectrum of the isolated compound. It had an 
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additional 20 1H’s  in the aliphatic region as well as all the characteristic signals of the 
substituted pyrrole moiety. 
N
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O
O
N
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3-63
 
Figure 3.4 DCC adduct of acid 
In an attempt to drive the reaction to completion the DCC adduct was dissolved in 
toluene and placed in the microwave reactor in the presence of DMAP and excess aniline 
in hopes that the extreme thermal conditions and pressure of the microwave would drive 
the reaction forward (Scheme 3.23). 
 
Scheme 3.23 DCC coupling under microwave conditions 
Microwave heating had no effect on the outcome of the reaction. Again only what was 
believed to be the DCC adduct was isolated from the reaction mixture. The apparent lack 
of reactivity of 3-61 was attributed to the steric demand of the starting material. At this 
point no further reactions with DCC were conducted and CDI couplings were skipped 
altogether.  
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The substrate required a reactive centre that was not much bulkier if at all then the 
carboxylic acid. We chose to examine the possibility of forming the acid chloride in-situ 
and then adding in aniline. The acid chloride is not much larger than that of the 
carboxylic acid and it is a highly reactive centre. The formation of the amide should 
provide a suitable thermodynamic sink to drive the reaction forward. 3-60 was treated 
with freshly distilled thionyl chloride in refluxing THF for 4 hours at which time aniline 
was added and the reaction continued to reflux for 12 hours according to Scheme 3.24.25 
N
HO2C
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F
Br
1. SOCl2, THF,
reflux, 4 h
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reflux, 12 h
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Scheme 3.24 Amide formation via acid chloride 
As it turns out on the first attempt with the two step amide formation 3-38 was 
successfully formed in a 65 % yield based on recovered starting material. The uppermost 
yield obtained with the reaction was 86 % BRSM however in our hands we could not 
continuously reproduce this result. Overall the moderate to excellent yields were quite 
satifying with such a sterically encumbered substrate. 
The final step was the Suzuki coupling to generate the completed PMP protected Lipitor® 
pyrrole. Gratifyingly following the same conditions used previously the Suzuki coupling 
was carried out successfully affording the much sought after PMP protected Lipitor® 
pyrrole as seen in Scheme 3.25.21  
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Scheme 3.25 Completion of the PMP protected pyrrole unit 
The complete forward synthesis of the PMP protected pyrrole from the initial 
cycloaddition reaction to the final Suzuki coupling can be seen in its entirety, with 
respective yields, in Scheme 3.26. 
 
Scheme 3.26 Completed synthesis of PMP protected Lipitor® pyrrole 
3.2.6 Attempts at Deprotection and a Formal Synthesis of Lipitor® 
With the completed pyrrole moiety only one more step was required to complete a formal 
synthesis of Lipitor®. The culmination of the synthesis was the deprotection of the PMP 
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group on the nitrogen atom. It has been brought to the attention of the scientific 
community, by Jacob Peyton et. al., that a PMP group on an aromatic nitrogen atom can 
be readily removed through the use of CAN.26 CAN acts as a mild oxidant converting the 
PMP group into a quinone following the general mechanism seen in Figure 3.5.26 
 
Figure 3.5 Mechanism of CAN deprotection 
The deptrotection would provide an intermediate which has been previously carried to the 
complete molecule; therefore the free N-H pyrrole would provide a formal synthesis of 
Lipitor®. According to the literature procedure three equivalents of CAN in a 4:1 
CH3CN:H2O solvent mixture will successfully remove a PMP group from a nitrogen 
atom in a matter of minutes. Admittedly the first time this experiment was conducted a 
slight error was made in the solvent ratio. A ratio of 2:1 was used instead of the reported 
4:1; the rest of the conditions matched that of the literature Scheme 3.27.  
 
Scheme 3.27 CAN promoted PMP deprotection 
Upon complete consumption of the starting material the reaction was quenched with 
NaHCO3 and extracted with Et2O. After obtaining 1H NMR spectrum we were overjoyed 
because we believed the deprotection had progressed smoothly and provided a formal 
synthesis of Lipitor®. However upon comparison of our 1H NMR spectrum to the 
literature spectrum there were two rather obvious inconsistencies. Both the H-N proton 
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and the methine iPr proton were significantly upfield according to multiple literature 
sources. To emphasize the drastic difference in chemical shift a direct comparison of the 
1H NMR spectra obtained from the experiment and the reported literature respectively 
can been seen below (Figure 3.6).27 
 
Figure 3.6 Experimental and literature 1H NMR spectra of the deprotected pyrrole 
In order to identify the unknown product it was crystallized by vapour diffusion with 
DCM:hexanes. Once the crystallographic data was gathered and solved the result was 
completely bewildering. It turns out that CAN had managed to remove the PMP group 
then concomitantly cleave the pyrrole ring forming a conjugated 1,4-imine-carbonyl 
compound (Scheme 3.28). The crystal structure of the compound produced can be seen in 
Figure 3.7. 
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Scheme 3.28 Result of CAN deprotection 
 
Figure 3.7 Crystal Structure if 1,4-imine, carbonyl 
What was most perplexing about this result was the fact that the imine itself was so stable 
that it could be crystallized, let alone survive the aqueous conditions of the reaction and 
the workup itself. On the bright side of things however the deprotection did occur. It is 
quite possible that the conditions could be controlled or altered in such a way that only 
the deprotection and not the ring cleavage will occur. Table 3.6 shows the various 
temperature, solvent and equivalencies of CAN employed to effectively remove the PMP 
group with CAN. 
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Table 3.6 Conditions attempted for CAN deprotection 
Equiv. of CAN Temperature Solvent Results 
3 RT CH3CN: H2O (2:1) Opened Product 
2 -30 °C CH3CN: H2O (4:1) No reaction 
2 0 °C CH3CN: H2O (4:1) No reaction 
2 RT CH3CN: H2O (4:1) No reaction 
3 -10 °C CH3CN: H2O (4:1) Decomposition 
3 0 °C CH3CN: H2O (4:1) Decomposition 
3 -10 °C THF: H2O (4:1) Decomposition 
3 0 °C THF: H2O (4:1) Decomposition 
3 RT Et2O: H2O (4:1) Decomposition 
3 -10 °C Et2O: H2O (4:1) Decomposition 
3 0 °C Et2O: H2O (4:1) Decomposition 
3 RT DCM: H2O (4:1) No reaction 
A large set of conditions were screened in order to successfully deprotect the nitrogen 
atom. In every case upon working up the reaction, dependent upon the temperature, a 
mixture of starting material, what appeared to be the open product and decomposition 
was formed based on 1H NMR analysis. Not once in any of the 1H NMR spectra gathered 
did was the evolution of a septet at approximately 4.11 ppm observed, indicating the 
desired product. Obtaining the free nitrogen via this route has proven futile so far. 
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A colleague had mentioned a piece of literature that reported the removal of a PMP group 
with periodic acid.28 With this information in hand the small amount of material (3-38) 
that remained was split into two to test the conditions outlined in the paper. The original 
work mentions that the reaction was conducted at room temperature however because of 
the lack of solubility of 3-38 under the specific solvent conditions it was predicted 
significant heating would be required to drive the reaction at all. As such the described 
reaction was carried out at both room temperature and refluxing conditions as seen in 
Scheme 3.29. 
HIO4, H2SO4
CH3CN:H2O( 1:1)
N
F
OMe
O
NH
H
N
O
NH
F
RT, O/N
HIO4, H2SO4
CH3CN:H2O( 1:1)
N
F
OMe
O
NH
H
N
O
NH
F
reflux, O/N
3-38 3-63
3-38 3-63
 
Scheme 3.29 Deprotection attempts with periodic acid 
Both efforts with periodic acid did not work. In both cases starting material was 
recovered and in the first case 3-39 did not dissolve in any appreciable amount, it 
remained as a suspension for the entire reaction period. Due to these results no further 
reactions with periodic acid. 
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3.3 Conclusions 
It appears that BM 212 cannot be accessed through the methodology outlined in chapter 
2. The inertness of acetaldehyde proved to be far too great a complication to overcome by 
simple altering of reaction conditions. It is most likely due to the fact that in the reaction 
an iminium species is generated and with the lack of substitution on the aldehyde there is 
no adequate donor group capable of stabilizing the partial positive charge on the iminium 
carbon. 
The core of Atorvastatin Calcium was accessed in comparable steps to that of the 
commercial synthesis. The poor yield obtained in the first step of the synthesis is 
relatively trivial because sizeable amounts of the inexpensive starting material could be 
generated rapidly. Therefore with continuous cycling of starting material through the first 
reaction a large stockpile of the necessary tetrahydro-1,2-oxazine could be quickly 
synthesized. The remainder of the synthesis albeit is linear but it is difficult to imagine 
any other convergent route to this material using our methodology. After formation of the 
first pyrrole ring it was simply a matter of altering the corresponding functional groups to 
form the drug core. Regrettably however the ring system is far too electron rich to survive 
the oxidative PMP deprotections attempted. There are still a few reactions remaining that 
could potentially remove the PMP protecting group. One being the use of argentic oxide 
in the presence of HNO3, another is a cobalt mediated deprotection in the presence of 
tbuOOH and finally perhaps buffering the solution while using CAN will prevent ring 
cleavage.29 Another possibility to utilize this work would be to investigate whether or not 
the conditions can be altered in such a way that the Tsuji dehydrocarbonylation reaction 
can occur with N-akyl substitution not just N-aryl. There still remains an enormous 
amount of work that can be done to further improve this methodology and complete the 
total synthesis. The outlined synthesis of Lipitor® is likely still viable however a 
significant degree of work needs to be carried out in order to fully uncover all the secrets 
of the Tsuji dehydrocarbonylation reaction. By fully understanding the reaction itself and 
all possible intermediates in the mechanism one could imagine tuning a substrate such 
that aliphatic hydroxylamines and nitrones could be used. Due to time constraints 
however this work will have to be carried on by a colleague. Nevertheless it is extremely 
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important to reiterate that the significance of the tetrahydro-1,2-oxazine to pyrrole 
conversion is in the utility to generate such a vast number of different pyrrole systems. 
3.4 Experimental Details for Chapter 3 
3.4.1 General Considerations 
For general considerations refer to section 2.4.1 General Considerations from Chapter 2. 
Experimental procedures for cyclopropane synthesis and the one pot conversion of 
tetrahydro-1,2-oxazines to pyrrole can be found in sections 2.4.2 and 2.4.5 from Chapter 
2 respectively.  
3.4.2 Experimental Procedures and Spectroscopic Data for BM 
212 
             
(1R*,2S*)-1-allyl-1-methyl-2-(4-chlorophenyl)cyclopropane-1,1-
dicarboxylate (3-26): White powder, Rf = 0.47 (30% EtOAc in 
hexanes); 1H NMR (400 MHz, CDCl3) δ 7.25 (d, J = 8.6 Hz, 2H), 7.13 
(d, J = 8.6 Hz, 2H), 5.93 (ddt, J = 17.2, 10.2, 5.5 Hz, 1H), 5.35 (dq, J = 17.2, 1.6 Hz, 1H), 
5.26 (dq, J = 10.6, 1.2 Hz, 1H), 4.75-4.62 (m, 2H), 3.42 (s, 3H), 3.20 (t, J = 9.0 Hz, 1H), 
2.17 (dd, J = 8.2, 5.5 Hz, 1H), 1.76 (dd, J = 9.0 Hz, 5.1 Hz, 1H); 13C NMR (100 MHz, 
CDCl3) δ 169.2, 166.8, 133.3, 131.6, 130.0, 128.3, 118.3, 66.2, 52.3, 37.3, 31.7, 19.2; 
FT-IR (thin film, cm-1) νmax 2951, 1728, 1496, 1438, 1379, 1332, 1275, 1216, 1179, 
1130, 1093, 1016, 983, 934, 837, 772, 713, 541; HRMS calc'd for C15H15ClO4 [M+] = 
294.0659 found 294.0662. 
             
N-(4-chlorophenyl)hydroxylamine (3-24): 3-32 (1.0 g, 6.37 mmol) and 
Zn dust (1.67 g, 25.40 mmol) were dissolved in CH3CN (25 mL) and sonicated at 25 °C 
for 30 minutes. After which time NH4HCO2 (4.01 g, 63.70 mmol) was added in one 
portion and the reaction was sonicated for a further 100 minutes. After the allotted 
timeframe the reaction was filtered through a Buchner Funnel and the crude material was 
CO2Me
CO2allyl
Cl
Cl
NHOH
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preabsorbed onto silica gel and purified by flash column chromatography (1:10, 
EtOAc/hexanes) affording 3-24 as a pale yellow powder (60 %, 0.55 g, 3.82 mmol). The 
spectral data matched that of literature data.11 
             
3.4.3 Experimental Procedures and Spectroscopic Data for 
Lipitor® 
             
(1R*,2S*)-1-allyl-1-methyl-2-(4-F-phenyl)cyclopropane-1,1-
dicarboxylate (3-43): Following the general procedure outlined in 
Chapter 2 for cyclopropane trans esterification afforded 3-43 as a yellow oil; Rf = 0.48 
(30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.18-7.15 (m, 2H), 6.98-6.95 (m, 
2H), 5.96-5.87 (m, 1H), 5.35 (app dq, J = 17.2, 1.6 Hz, 1H), 5.26 (app dq, J = 10.6, 1.2 
Hz, 1H), 4.76-4.62 (m, 2H), 3.40 (s, 3H), 3.21 (t, J = 9.0 Hz, 1H), 2.16 (dd, J = 8.4, 5.5 
Hz, 1H), 1.75 (dd, J = 9.4, 5.5 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 169.2, 166.9, 
163.3, 160.6, 131.6, 130.2, 130.1, 118.2, 115.2, 115.0, 66.1, 52.2, 37.1, 31.7, 19.2; FT-IR 
(thin film, cm-1) νmax 2996, 2952, 2360, 1728, 1608, 1515, 1438, 1379, 1332, 1275, 1217, 
1131, 934, 843; HRMS calc’d for C11H10FO2 [M+] 278.0954 found 278.0956. 
             
N-(4-methoxyphenyl)hydroxylamine (3-41): To a suspension of 3-50 (5 
g, 33 mmol) and NH4Cl (1.9 g, 36 mmol) in a 1:1 mixture of H2O:EtOH (50 mL) Zn dust 
(8 g, 132 mmol) was added portionwise over 15 minutes. After addition was complete the 
reaction was allowed to stir for an additional 10 minutes. After the allotted time the 
reaction was filtered through a Buchner funnel and 30 mL of brine was added to the 
CO2allyl
CO2Me
F
MeO
NHOH
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filtrate. The filtrate was cooled in an ice salt bath until crystallization was complete and 
then filtered again through a Buchner funnel providing 3-43 (2.3 g, 17 mmol, 50 %) as 
yellow crystals. The spectral data gathered matched that of the literature data provided.ref 
            
 
tert-butylhydroxycarbamate (3-53): BOC-hydroxylamine was synthesized 
according to the literature procedure.15 To a mixture of hydroxylamine hydrochloride (1.0 
g, 14 mmol)  in water (15 mL) and DCM (15 mL) at 0 °C was added NaHCO3 (2.2 g, 25 
mmol) portionwise. After 10 min di-tbutyldicarbonate (2.5 g, 11 mmol) was added 
dropwise. The reaction mixture was allowed to warm to room temperature overnight after 
which time  the aqueous layer was separated and extracted with DCM (2x 20 mL). The 
combined extracts were washed with a saturated NaHCO3 solution (50 mL) and brine (50 
mL), dried over MgSO4 and concentrated to afforded 3-52 (67 %, 1.3 g, 9.4 mmol) as a 
colourless oil. The spectroscopic data was consistent with that of the literature data.15 
            
 
(E)-4-methoxy-N-(2-methylpropylidene)aniline oxide (3-55): To  flask 
charged with 3-41 (5 g, 36.00 mmol) 4 Å MS (2 g) and isobutyraldehyde 
(10.0 mL, 108.00 mmol) was added anhydrous toluene and then placed under an 
atmosphere of Ar. The reaction was allowed to stir for 24 h after which time it was 
filtered through a sintered glass funnel. Toluene was removed under reduced pressure and 
the remaining residue was dissolved in a minimal amount of hexanes and placed in the 
−20 °C freezer. After crystallization was complete the crystals were obtained through 
Buchner filtration while washing with cold hexanes affording 3-41 (50 %, 3.74 g, 18.0 
MeO
N
O
O NHOH
O
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mmol) as orange crystals; Rf = 0.03 (30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) 
δ 7.63-7.57 (m, 2H), 7.00 (d, J = 7.4 Hz, 2H), 6.93-6.87 (m, 2H), 3.83 (s, 3H), 3.36 (m, J 
= 6.8, 1H), 1.21 (d, J = 7.0 Hz, 6H); 13C NMR (100 MHz, CDCl3) δ 160.4, 143.8, 141.0, 
122.8, 113.8, 55.5, 26.6, 18.9; FT-IR (thin film, cm-1) νmax 2963, 1598, 1505, 1463, 1254, 
1076, 1030, 839, 600; HRMS calc’d for C11H15NO2 [M+] 193.1103 found 193.1096. 
             
3R,6R)-4-allyl-4-methyl-6-(4-fluorophenyl)-3-isopropyl-2-(4-
methoxyphenyl)morpholine-4,4-dicarboxylate (3-40): To a 
solution of cyclopropane 3-43 (278 mg, 1 mmol) dissolved in 10 mL of anhydrous 
toluene with 4 Å MS (200 mg), was added nitrone 3-55 (251 mg, 1.3 mmol) and MgI2 
(42 mg, 15 mol%). The reaction was then placed under an atmosphere of Ar and allowed 
to stir for 24 hours at room temperature. After filtration and purification (flash column 
chromatography, EtOAc/hexanes 1:20) tetrahdyro-1,2-oxazine 3-40 was isolated as a  
yellow viscous oil (60 %, 0.60 mmol, 10:1 diastereomeric mixture at C4); Rf = 0.45 (30% 
EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.45-7.38 (m, 2H), 7.12-7.05 (m, 2H), 
7.01-6.95 (m, 2H), 6.83-6.75 (m, 2H), 5.97-5.85 (m, 1H), 5.38-5.30 (m, 1H), 5.30-5.22 
(m, 1H), 4.86-4.79 (m, 1H), 4.76-4.65 (m, 2H), 4.59-4.51 (m, 2H), 3.81 (s, 1H), 3.4 (s, 
5H), 2.72-2.53 (m, 2H), 2.39 (m, J = 6.6 Hz, 1H), 0.91 (t, J = 6.7 Hz, 3H), 0.87-0.81 (m, 
3H); 13C NMR (100 MHz, CDCl3) δ 170.4, 169.5, 169.4, 168.7, 163.7, 161.3, 153.3, 
143.5 (x2), 135.6 (x3), 135.5, 131.6, 131.0, 128.2 (x2), 128.1 (x2), 118.9, 118.8, 115.4, 
115.2, 114.2, 114.1 (x3), 67.4, 67.3, 66.6, 66.2, 29.1 (x2), 22.4, 22.2, 22.1; FT-IR (thin 
film, cm-1) νmax; HRMS calc’d for C26H30FNO6 [M+] 471.2057 found 471.1987. 
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methyl 5-(4-fluorophenyl)-2-isopropyl-1-(4-methoxyphenyl)-1H-
pyrrole-3-carboxylate (3-39): Following general method B outlined 
in Chapter 2 (one-pot procedure), tetrahydro-1,2-oxazine 3-40 (471 
mg, 1 mmol) and Pd2dba3 (55 mg, 6 mol %) were dissolved in CH3CN (5 mL, 80 °C, 3 h) 
and refluxed for 3 h. After which time the reaction was cooled to room temperature and 
DBU (450 µL, 3 mmol) was added (5 min) affording 3-39 (70 %, 257 mg, 0.70 mmol ) as 
a yellow powder; Rf = 0.45 (30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.07-
7.03 (m, 2H), 7.02-6.97 (m, 2H), 6.90-6.86 (m, 2H), 6.96-6.80 (m, 2H), 6.73 (s, 1H), 3.84 
(s, 3H), 3.83 (s, 3H), 3.10 (m, J = 7.0 Hz, 1H), 1.30 (d, J = 7.0 Hz, 6H); 13C NMR (100 
MHz, CDCl3) δ 165.3, 162.8, 160.3, 159.4, 147.5, 132.5, 130.9, 130.1, 130.0, 129.9, 
128.7 (x2), 1150, 114.8, 114.2, 111.3, 110.9, 55.4, 50.9, 26.7, 20.4; FT-IR (thin film, cm-
1) νmax; 2960, 2275, 1710, 1564, 1513, 1490, 1243, 1222, 1181, 1108, 1043, 840, 780, 
544; HRMS calc’d for C22H22FNO3 [M+] 367.1584 found 367.1590. 
             
methyl-4-bromo-5-(4-fluorophenyl)-2-isopropyl-1-(4-
methoxyphenyl)-1H-pyrrole-3-carboxylate (3-58): Pyrrole 3-39 (330 
mg, 0.90 mmol) was dissolved in DMF (10 mL) and cooled to 0 °C, at 
which point NBS (178 mg, 1 mmol) was added in as one portion and the reaction was 
allowed to warm to room temperature while stirring for one hour. Upon complete 
consumption of the starting material based on TLC analysis 15 mL of H2O was added to 
the reaction mixture. The organics were extract 3x with Et2O and then washed with H2O 
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and brine. The organic layer was dried over MgSO4 and after filtration and removal of 
solvent under reduced pressure pyrrole 3-58 (75 %, 300 mg, 0.63 mmol) was obtained as 
a yellow powder; Rf = 0.47 (30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.13-
7.07 (m, 2H), 6.99-6.95 (m, 2H), 6.91-6.86 (m, 2H), 6.82-6.78 (m, 2H), 3.90 (s, 3H), 3.79 
(s, 3H), 3.08 (m, J = 7.0 Hz, 1H), 1.24 (d, J = 7.0 Hz, 6H); 13C NMR (100 MHz, CDCl3) 
δ 165.1, 163.2, 160.1, 159.4, 145.4, 132.8, 132.7, 131.7, 130.3, 129.9, 126.9, 126.8, 
115.0, 114.8, 114.0, 111.6, 97.4, 55.4, 51.1, 27.1, 21.0; FT-IR (thin film, cm-1) νmax 2960, 
1708, 1513, 1488, 1243, 1169, 1111, 1044, 842, 732, 540; HRMS calc’d for 
C22H21BrFNO3 [M+] 445.0689 found 445.0672. 
             
Methyl-5-(4-fluorophenyl)-2-isopropyl-1-(4-methoxyphenyl)-4-
phenyl-1H-pyrrole-3-carboxylate (3-59):  3-58 (100 mg, 0.22 mmol) 
was dissolved in degassed DMF (8 mL) and put under an atmosphere 
of Ar. At which time PhB(OH)2 (41 mg, 0.34 mmol), Pd(PPh3)4 (10 mol %, 0.022 mmol, 
26 mg) and K2CO3 (2M, 0.45 mmol, 220 µL) were added in succession. The reaction was 
then heated to 110 °C for 4 hours. After complete consumption of the starting material 
based on TLC analysis the reaction was filtered through celite and 10 mL of H2O was 
added. The organics were extracted 3x with Et2O and the organic layer was washed with 
H2O and brine. After filtration and purification by flash column chromatography 
(EtOAc/hexanes, 1:20) compound 3-59 (82 %, 81 mg, 0.18 mmol) was obtained as a 
yellow powder; Rf = 0.45 (30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.20-
7.12 (m, 5H), 7.05 (app d, J = 8.6 Hz, 2H), 6.85-6.81 (m, 4H), 6.73-6.67 (app t, J = 9.0 
Hz, 2H), 3.80 (s, 3H), 3.13 (m, J = 7.0 Hz, 1H), 1.29 (d, J = 7.0 Hz, 6H); 13C NMR (100 
N
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MHz, CDCl3) δ 167.0, 162.7, 160.2, 159.2, 144.3, 135.6, 133.0, 132.9, 130.7, 130.5, 
130.4, 130.2, 127.9 (x2), 127.3, 125.8, 123.7, 114.6, 114.4, 113.9, 111.2, 55.4, 50.8, 26.7, 
21.3; FT-IR (thin film, cm-1) νmax; 2960, 2361, 1705, 1512, 1250, 1174, 1242, 846, 733, 
700, 544; HRMS calc’d for C28H26FNO3 [M+] 443.1897 found 443.1899. 
             
4-bromo-5-(4-fluorophenyl)-2-isopropyl-1-(4-methoxyphenyl)-1H-
pyrrole-3-carboxylic acid (3-61): To a flask charged with pyrrole 3-58 
(274 mg, 0.61 mmol) was added NaOH (1.7 M, 18 mL, 30.70 mmol) 
and an equal volume of MeOH (18 mL). The reaction temperature was increased to 100 
°C and allowed to reflux for 20 hours. After which time the reaction was cooled to room 
temperature and acidified with 2 M HCl. The organics were extracted 3x with Et2O, the 
organic layer was washed with brine and dried over MgSO4. After filtration and flash 
column chromatography (EtOAc/hexanes 1:10) pyrrole 3-61 (88 %, 127 mg, 0.29 mmol) 
was isolated as clear colourless needles; Rf = 0.22  (30% EtOAc/hexanes); 1H NMR (400 
MHz, d6-DMSO) δ 12.42 (s, 1H), 7.22-7.17 (m, 4H), 7.08-7.03 (m, 2H), 6.90-6.88 (m, 
2H), 3.72 (s, 3H), 2.98 (m, J = 7.4 Hz, 1H), 1.17 (d, J = 7.0 Hz, 6H); 13C NMR (100 
MHz, d6-DMSO) δ 165.4, 160.2, 159.0, 144.2, 133.2, 133.1, 131.1, 130.3, 129.8, 127.1 
(x2), 114.9, 114.7, 114.0, 111.8, 96.8, 55.3, 26.5, 20.7; FT-IR (thin film, cm-1) νmax 2960, 
2590, 2361, 1735, 1673, 1513, 1489, 1256, 846, 539; HRMS calc’d for C21H19BrFNO3 
[M+] 431.0532 found 431.0530. 
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4-bromo-5-(4-fluorophenyl)-2-isopropyl-1-(4-methoxyphenyl)-N-
phenyl-1H-pyrrole-3-carboxamide (3-38): 3-61 (79 mg, 0.18 mmol) 
was dissolved in THF at room temperature and place under an 
atmosphere of Ar. Freshly distilled SOCl2 (20 µL, 0.28 mmol) was 
added dropwise and the reaction brought to reflux for 4 hours. At this 
time the reaction was cooled to room temperature and aniline (33 µL, 0.38 mmol) was 
added dropwise. The reaction was brought back to reflux for another 12 hours. Upon 
complete consumption of the acid chloride based on TLC analysis the reaction was 
cooled to 0 °C and quenched with H2O. The organics were extracted 3x with DCM and 
the organic layer was washed with H2O and brine. After filtration and flash column 
chromatography (EtOAc/ hexanes 1:20) pyrrole 3-38 (86 % BRSM, 71 mg, 0.14 mmol) 
was obtained as a yellow powder; Rf = 0.40  (30% EtOAc/hexanes); 1H NMR (400 MHz, 
CDCl3) δ 7.90 (s, 1H), 7.68 (app d, J = 7.8 Hz, 2H), 7.38 (app t, J = 7.8 Hz, 2H), 7.16-
7.10 (m, 3H), 7.03-7.00 (m, 2H), 6.93-6.89 (m, 2H), 6.84-6.80 (m, 2H), 3.80 (s, 3H), 3.08 
(m, J = 7.0 Hz, 1H), 1.30 (d, J = 7.0 Hz, 6H); 13C NMR (100 MHz, CDCl3) δ 163.3, 
163.1, 160.8, 159.4, 143.5, 138.3, 132.7, 132.6, 130.9, 130.3, 130.0, 129.0, 126.7 (x2), 
124.1, 120.0, 116.1, 115.1, 114.9, 114.1, 94.8, 55.4, 27.1, 21.6; FT-IR (thin film, cm-1) 
νmax 3415, 2963, 1667, 1596, 1512, 1438, 1248, 1169, 908, 842, 732, 691, 580; HRMS 
calc’d for C27H24BrFN2O2 [M+] 506.1005 found 506.1008. 
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5-(4-fluorophenyl)-2-isopropyl-1-(4-methoxyphenyl)-N,4-diphenyl-
1H-pyrrole-3-carboxamide (3-37): 3-38 (366 mg, 0.72 mmol) was 
dissolved in degassed DMF (15 mL) and put under an atmosphere of 
Ar. At which time PhB(OH)2 (132 mg, 1.08 mmol), Pd(PPh3)4 (10 mol 
%, 84 mg, 0.072 mmol) and K2CO3 (2M, 1.44 mmol, 0.72 mL) were added in succession. 
The reaction was then heated to 110 °C for 4 hours. After complete consumption of the 
starting material based on TLC analysis the reaction was filtered through celite and 10 
mL of H2O was added. The organics were extracted 3x with Et2O and the organic layer 
was washed with H2O and brine. After filtration and purification by flash column 
chromatography (EtOAc/hexanes, 1:20) compound 3-37 (85 %, 312 mg, 0.61 mmol) was 
obtained as a yellow powder; Rf = 0.42 (30% EtOAc/hexanes); 1H NMR (400 MHz, 
CDCl3) δ 7.27-7.17 (m, 7H), 7.12-7.07 (m, 4H), 7.03-6.97 (m, 1H), 6.95 (s, 1H), 6.90-
6.82 (m, 4H), 6.75-6.68 (m, 2H), 3.81 (s, 3H), 3.22 (m, J = 7.04 Hz, 1H), 1.35 (d, J = 
7.04 Hz, 6H); 13C NMR (100 MHz, CDCl3) δ  159.2, 183.3, 134.6, 132.9, 132.8, 130.7, 
130.7, 130.3, 130.1, 128.7, 128.5, 127.8, 127.8, 126.8, 123.6, 121.4, 119.6, 115.4, 114.7, 
114.5, 113.9, 55.4, 26.7, 21.5; FT-IR (thin film, cm-1) νmax 3408, 2931, 2360, 1665, 1594, 
1512, 1436, 1250, 1178, 1039, 909, 946, 732; HRMS calc’d for C33H29FN2O2 [M+] 
504.2213 found 504.2224. 
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Appendix 1: 1H and 13C NMR Spectra for Chapter 2 
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Appendix 2: 1H and 13C NMR Spectra for Chapter 3 
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